咸蛋超人POT的个人主页 - 老虎社区

咸蛋超人POT

咸蛋超人POT

股票呆呆

IP属地：未知

10关注

4粉丝

0主题

0勋章

咸蛋超人POT

2021-12-29

is this author a paid FUDster?

5 Stocks I'd Sell Right Now

咸蛋超人POT

2021-12-28

‌$Cassava Sciences Inc(SAVA)$‌True Science will kill the Shorts.

咸蛋超人POT

2021-12-15

AiYO, why tiger articles are getting more toxicnowadays like seeking alpha and motley fools.Flip prata from so many news channels.

Renewed Selling Pressure Likely For Singapore Stock Market

咸蛋超人POT

2021-12-13

must come down first then can hoot.

Tesla Stock: Headed to $1,580?

咸蛋超人POT

2021-12-13

rollercoaster piece; sitting on bench

Lucid Group jumped nearly 10% in premarket trading

咸蛋超人POT

2021-12-13

finally its standing up shining like a star.

Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra

咸蛋超人POT

2021-12-13

CHPT a contrary sentiment; pull and push effect due to their quality. AMRS go go go!

3 Growth Stocks to Fuel Your 2022 Financial Freedom

咸蛋超人POT

2021-12-08

up & down; undecided sentiments

Some Vaccine stocks corrected in premarket trading

咸蛋超人POT

2021-12-07

time to layer in; OVERSOLD by sentiments!

Hot Chinese ADRs continued to rise in premarket trading

咸蛋超人POT

2021-12-03

now this is getting interesting. Tonight chinese ADRs plunge?

DIDI prepares to delist from U.S. stocks and to list in Hong Kong.

咸蛋超人POT

2021-12-02

Buy Pfizer, Moderna says theirs not that effective against new variant 🤣

Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?

咸蛋超人POT

2021-11-21

unexpected bonus of a pullback; get ready for an early christmas discount

抱歉，原内容已删除

咸蛋超人POT

2021-11-16

legalize it than having it grown into a huge dark market

抱歉，原内容已删除

咸蛋超人POT

2021-11-12

the sector that have been greatly neglect. Same goes on $TLRY - give them a bit of time and they'll shine.

Sundial Growers shares jumped nearly 30% in premarket trading

咸蛋超人POT

2021-11-12

another missed expectations. all hyped.

Lordstown Motors shares fell 10.6% in premarket trading

咸蛋超人POT

2021-11-12

all the expectations missed.

抱歉，原内容已删除

咸蛋超人POT

2021-09-03

$Cassava Sciences Inc(SAVA)$It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call]

咸蛋超人POT

2021-08-28

$Cassava Sciences Inc(SAVA)$Lunch break isover, time to go GREEN![Smart]

咸蛋超人POT

2021-08-28

$Cassava Sciences Inc(SAVA)$ SQUEEZE the BEARS!!!

咸蛋超人POT

2021-08-27

$Cassava Sciences Inc(SAVA)$ Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3575010783330312","uuid":"3575010783330312","gmtCreate":1612181250199,"gmtModify":1636088794261,"name":"咸蛋超人POT","pinyin":"xdcrpotxiandanchaorenpot","introduction":"","introductionEn":"","signature":"股票呆呆","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":10,"tweetSize":21,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.31","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.10%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.92%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":692038090,"gmtCreate":1640789614349,"gmtModify":1640789614445,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"is this author a paid FUDster?","listText":"is this author a paid FUDster?","text":"is this author a paid FUDster?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692038090","repostId":"2195545489","repostType":2,"repost":{"id":"2195545489","kind":"highlight","pubTimestamp":1640780993,"share":"https://www.laohu8.com/m/news/2195545489?lang=&edition=full","pubTime":"2021-12-29 20:29","market":"us","language":"en","title":"5 Stocks I'd Sell Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2195545489","media":"Motley Fool","summary":"These could be some of the worst-performing and riskiest investments in 2022.","content":"<html><head></head><body><p>For many investors, the New Year is a time of reflection. They&#39;re thinking about what trends they want to buy into for the upcoming year and what stocks might help make them rich.</p><p>However, reflection is a two-way street. Just as there are great companies that can make investors wealthy, there are stocks that could cost investors a lot of money and should be avoided at all costs. Below are five stocks investors should consider selling right now.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9a8aaeae4465770036314f05da71f414\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>AMC Entertainment</h2><p>It&#39;s no secret that I believe movie theater chain <b>AMC Entertainment</b> (NYSE:AMC) is the most overvalued stock on Wall Street.</p><p>For those of you who may not have followed the AMC &#34;made for TV drama&#34; that&#39;s occurred this year, the company&#39;s shares are up more than 1,200% following an epic short squeeze earlier this year. Short-sellers (investors betting on a security&#39;s price to decline) were caught off-guard when AMC was able to save itself from imminent bankruptcy by selling 164 million shares of stock and issuing high-interest debt. But with this short squeeze now in the rearview mirror, AMC&#39;s abysmal operating performance, bloated balance sheet, and declining bargaining power with movie studios are in plain view.</p><p>For example, before the pandemic took effect, AMC was regularly securing theatrical exclusivity deals of 75 to 90 days. Nowadays, AMC is lucky to secure 45-day theatrical exclusivity. Even taking into account that most revenue is picked up in the first couple of weeks, this 30- to 45-day reduction in exclusivity is going to pinch AMC. It&#39;s also bad news considering that inflation-adjusted domestic box office sales have been in decline since 2002.</p><p>The bigger issue, as I&#39;ve stated over and over, is AMC can&#39;t make good on its liabilities. It has $5.45 billion in outstanding debt at roughly an 8% average interest rate. Keep that rate in mind, because lending rates are pretty much at historic lows. It also has over $1 billion in aggregate debt due in late 2026 and mid-2027 that&#39;s valued at more than 30% below face value. With the company hemorrhaging cash and not able to sell any additional stock thanks to its impassioned but misguided retail investors, it looks to be making a slow walk toward a chapter 11 bankruptcy reorganization.</p><p>Suffice it to say, AMC Entertainment is a stock investors can confidently sell right now.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b45c4bd410befdb22fd801c7758dfb71\" tg-width=\"700\" tg-height=\"525\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>MicroStrategy</h2><p>A second stock investors should strongly consider selling right now is &#34;enterprise analytics software company&#34; <b>MicroStrategy</b> (NASDAQ:MSTR). I have &#34;enterprise analytics software company&#34; in quotations because CEO Michael Saylor has effectively ignored this stagnant part of the company&#39;s operations and turned MicroStrategy into a leveraged gamble on <b>Bitcoin</b> (CRYPTO:BTC).</p><p>According to the company&#39;s investor presentation earlier this month, it&#39;s holding 122,478 Bitcoin at an average price of $29,861.  The issue with this strategy is threefold, in my view.</p><p>First, I&#39;m not convinced Bitcoin is a sound investment. I recently outlined my views on Bitcoin, which centers on its false scarcity and it&#39;s less-than-stellar network performance. Bitcoin is constantly being out-innovated when it comes to payments and nonfinancial blockchain applications.</p><p>Second, MicroStrategy destroyed a reasonably safe balance sheet by piling on more than $2 billion in debt and issuing $900 million in stock, all of which was used to buy Bitcoin. Saylor has leveraged a public company&#39;s future on an asset that produces nothing.</p><p>And third, I believe Saylor is a poor leader. Earlier this year, Saylor told the world in an interview to &#34;go mortgage your house and buy Bitcoin with it.&#34; This is <i>incredibly</i> <i>bad</i> <i>advice</i>, and all the more reason to avoid MicroStrategy.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0a442339ef77177eb97fecfa070c7ac0\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>Cassava Sciences</h2><p>Another stock investors can sell right now is clinical-stage biotech stock <b>Cassava Sciences</b> (NASDAQ:SAVA).</p><p>Cassava made waves in the first quarter when it announced positive interim analysis data from its open-label study of simufilam for patients with Alzheimer&#39;s disease. The data showed both cognition and behavior score improvements at the six-month mark. Since Alzheimer&#39;s has no cure, any positive clinical data tends to be well-received.</p><p>But there are two glaring issues that should send folks scurrying to the sidelines. First of all, the track record of success for clinical-stage therapeutics targeting Alzheimer&#39;s disease is incredibly low. While we&#39;ve witnessed plenty of early stage success, virtually all late-stage Alzheimer&#39;s trials end in failure. This isn&#39;t a knock against the research, so much as recognizing that tackling the blood-brain barrier is tricky.</p><p>The second concern is that Cassava Sciences is facing allegations of manipulating its trial data. The company also announced in November that federal agencies are investigating its practices, without specifically naming the federal agencies in question. Keeping in mind that some of the allegations have come from firms shorting the stock, this is a headache you&#39;re better off letting someone else deal with.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b3b1defb6dba4980112c9a56af41a57c\" tg-width=\"700\" tg-height=\"393\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>GameStop</h2><p>Investors should also considering selling the original meme stock, <b>GameStop</b> (NYSE:GME).</p><p>A few weeks before AMC ascended to the heavens on its short squeeze, GameStop&#39;s high short interest attracted retail investors. In fact, GameStop&#39;s short interest was higher than any publicly traded company, as of mid-January, making it the perfect candidate for an epic squeeze. However, with this short-term event now over, investors are forced to grapple with GameStop&#39;s poor operating performance.</p><p>On the positive side, GameStop was able to raise sufficient capital from selling its stock to rid its balance sheet of debt. This net-cash position, coupled with the long-term growth potential of digital gaming, means there are no bankruptcy concerns, unlike with AMC.</p><p>But GameStop was notably late in shifting its strategy to include digital gaming. Nowadays, the company is busy shuttering stores in an effort to lower its expenses and back its way into the profit column. The company&#39;s large brick-and-mortar presence is expected to work against it for the foreseeable future, and could keep it from profitability for a few years.</p><p>Further, Wall Street has been unimpressed with management&#39;s lack of concrete steps that&#39;ll be taken to turn the business around. Even with a hefty cash balance, GameStop is grossly overvalued.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2bd808070a9dde55f37210b59edc2e23\" tg-width=\"700\" tg-height=\"393\" width=\"100%\" height=\"auto\"/><span>A Tesla Model S charging. Image source: Tesla Motors.</span></p><h2>Tesla Motors</h2><p>Last, but certainly not least, investors should consider giving electric vehicle (EV) manufacturer <b>Tesla Motors</b> (NASDAQ:TSLA) the boot.</p><p>Tesla has managed to do a lot of great things with its first-mover advantage. The company is on pace to deliver more than 800,000 EVs in 2021, and CEO Elon Musk has watched his company deliver its two largest operating profits since inception this year. The range, capacity, and power associated with Tesla&#39;s batteries has been superior as well.</p><p>Yet, these competitive advantages are unlikely to last given that all of the world&#39;s largest auto companies are throwing billions of dollars at EV research. For instance, <b>General Motors</b> and <b>Ford Motor Company</b> are respectively investing $35 billion and $30 billion in next-generation automobiles, with both companies bringing 30 new EVs to market by 2025. Tesla&#39;s first-mover advantage will fade sooner than later.</p><p>What&#39;s more, Tesla&#39;s income statement has been aided by selling Bitcoin at a profit earlier this year, as well as selling renewable energy credits (RECs) to other automakers. Take away these RECs and Tesla&#39;s profits aren&#39;t even remotely as impressive.</p><p>Valued at nearly 130 times Wall Street&#39;s forward-year earnings in an industry where single-digit earnings multiples are commonplace, I&#39;d have to think Tesla&#39;s stock is due for a major reversion.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks I'd Sell Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks I'd Sell Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-29 20:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/29/5-stocks-id-sell-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For many investors, the New Year is a time of reflection. They're thinking about what trends they want to buy into for the upcoming year and what stocks might help make them rich.However, reflection ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/29/5-stocks-id-sell-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4108":"电影和娱乐","SAVA":"Cassava Sciences Inc","GME":"游戏驿站","AMC":"AMC院线","BK4527":"明星科技股","BK4547":"WSB热门概念","BK4534":"瑞士信贷持仓","TSLA":"特斯拉","MSTR":"MicroStrategy","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4555":"新能源车","BK4023":"应用软件","BK4007":"制药","BK4099":"汽车制造商","BK4076":"电脑与电子产品零售","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/29/5-stocks-id-sell-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195545489","content_text":"For many investors, the New Year is a time of reflection. They're thinking about what trends they want to buy into for the upcoming year and what stocks might help make them rich.However, reflection is a two-way street. Just as there are great companies that can make investors wealthy, there are stocks that could cost investors a lot of money and should be avoided at all costs. Below are five stocks investors should consider selling right now.Image source: Getty Images.AMC EntertainmentIt's no secret that I believe movie theater chain AMC Entertainment (NYSE:AMC) is the most overvalued stock on Wall Street.For those of you who may not have followed the AMC \"made for TV drama\" that's occurred this year, the company's shares are up more than 1,200% following an epic short squeeze earlier this year. Short-sellers (investors betting on a security's price to decline) were caught off-guard when AMC was able to save itself from imminent bankruptcy by selling 164 million shares of stock and issuing high-interest debt. But with this short squeeze now in the rearview mirror, AMC's abysmal operating performance, bloated balance sheet, and declining bargaining power with movie studios are in plain view.For example, before the pandemic took effect, AMC was regularly securing theatrical exclusivity deals of 75 to 90 days. Nowadays, AMC is lucky to secure 45-day theatrical exclusivity. Even taking into account that most revenue is picked up in the first couple of weeks, this 30- to 45-day reduction in exclusivity is going to pinch AMC. It's also bad news considering that inflation-adjusted domestic box office sales have been in decline since 2002.The bigger issue, as I've stated over and over, is AMC can't make good on its liabilities. It has $5.45 billion in outstanding debt at roughly an 8% average interest rate. Keep that rate in mind, because lending rates are pretty much at historic lows. It also has over $1 billion in aggregate debt due in late 2026 and mid-2027 that's valued at more than 30% below face value. With the company hemorrhaging cash and not able to sell any additional stock thanks to its impassioned but misguided retail investors, it looks to be making a slow walk toward a chapter 11 bankruptcy reorganization.Suffice it to say, AMC Entertainment is a stock investors can confidently sell right now.Image source: Getty Images.MicroStrategyA second stock investors should strongly consider selling right now is \"enterprise analytics software company\" MicroStrategy (NASDAQ:MSTR). I have \"enterprise analytics software company\" in quotations because CEO Michael Saylor has effectively ignored this stagnant part of the company's operations and turned MicroStrategy into a leveraged gamble on Bitcoin (CRYPTO:BTC).According to the company's investor presentation earlier this month, it's holding 122,478 Bitcoin at an average price of $29,861.  The issue with this strategy is threefold, in my view.First, I'm not convinced Bitcoin is a sound investment. I recently outlined my views on Bitcoin, which centers on its false scarcity and it's less-than-stellar network performance. Bitcoin is constantly being out-innovated when it comes to payments and nonfinancial blockchain applications.Second, MicroStrategy destroyed a reasonably safe balance sheet by piling on more than $2 billion in debt and issuing $900 million in stock, all of which was used to buy Bitcoin. Saylor has leveraged a public company's future on an asset that produces nothing.And third, I believe Saylor is a poor leader. Earlier this year, Saylor told the world in an interview to \"go mortgage your house and buy Bitcoin with it.\" This is incredibly bad advice, and all the more reason to avoid MicroStrategy.Image source: Getty Images.Cassava SciencesAnother stock investors can sell right now is clinical-stage biotech stock Cassava Sciences (NASDAQ:SAVA).Cassava made waves in the first quarter when it announced positive interim analysis data from its open-label study of simufilam for patients with Alzheimer's disease. The data showed both cognition and behavior score improvements at the six-month mark. Since Alzheimer's has no cure, any positive clinical data tends to be well-received.But there are two glaring issues that should send folks scurrying to the sidelines. First of all, the track record of success for clinical-stage therapeutics targeting Alzheimer's disease is incredibly low. While we've witnessed plenty of early stage success, virtually all late-stage Alzheimer's trials end in failure. This isn't a knock against the research, so much as recognizing that tackling the blood-brain barrier is tricky.The second concern is that Cassava Sciences is facing allegations of manipulating its trial data. The company also announced in November that federal agencies are investigating its practices, without specifically naming the federal agencies in question. Keeping in mind that some of the allegations have come from firms shorting the stock, this is a headache you're better off letting someone else deal with.Image source: Getty Images.GameStopInvestors should also considering selling the original meme stock, GameStop (NYSE:GME).A few weeks before AMC ascended to the heavens on its short squeeze, GameStop's high short interest attracted retail investors. In fact, GameStop's short interest was higher than any publicly traded company, as of mid-January, making it the perfect candidate for an epic squeeze. However, with this short-term event now over, investors are forced to grapple with GameStop's poor operating performance.On the positive side, GameStop was able to raise sufficient capital from selling its stock to rid its balance sheet of debt. This net-cash position, coupled with the long-term growth potential of digital gaming, means there are no bankruptcy concerns, unlike with AMC.But GameStop was notably late in shifting its strategy to include digital gaming. Nowadays, the company is busy shuttering stores in an effort to lower its expenses and back its way into the profit column. The company's large brick-and-mortar presence is expected to work against it for the foreseeable future, and could keep it from profitability for a few years.Further, Wall Street has been unimpressed with management's lack of concrete steps that'll be taken to turn the business around. Even with a hefty cash balance, GameStop is grossly overvalued.A Tesla Model S charging. Image source: Tesla Motors.Tesla MotorsLast, but certainly not least, investors should consider giving electric vehicle (EV) manufacturer Tesla Motors (NASDAQ:TSLA) the boot.Tesla has managed to do a lot of great things with its first-mover advantage. The company is on pace to deliver more than 800,000 EVs in 2021, and CEO Elon Musk has watched his company deliver its two largest operating profits since inception this year. The range, capacity, and power associated with Tesla's batteries has been superior as well.Yet, these competitive advantages are unlikely to last given that all of the world's largest auto companies are throwing billions of dollars at EV research. For instance, General Motors and Ford Motor Company are respectively investing $35 billion and $30 billion in next-generation automobiles, with both companies bringing 30 new EVs to market by 2025. Tesla's first-mover advantage will fade sooner than later.What's more, Tesla's income statement has been aided by selling Bitcoin at a profit earlier this year, as well as selling renewable energy credits (RECs) to other automakers. Take away these RECs and Tesla's profits aren't even remotely as impressive.Valued at nearly 130 times Wall Street's forward-year earnings in an industry where single-digit earnings multiples are commonplace, I'd have to think Tesla's stock is due for a major reversion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":684,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696663312,"gmtCreate":1640683833505,"gmtModify":1640685636531,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"‌<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>‌True Science will kill the Shorts.","listText":"‌<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>‌True Science will kill the Shorts.","text":"‌$Cassava Sciences Inc(SAVA)$‌True Science will kill the Shorts.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696663312","isVote":1,"tweetType":1,"viewCount":662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607825628,"gmtCreate":1639526931755,"gmtModify":1639533389982,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"AiYO, why tiger articles are getting more toxicnowadays like seeking alpha and motley fools.Flip prata from so many news channels.","listText":"AiYO, why tiger articles are getting more toxicnowadays like seeking alpha and motley fools.Flip prata from so many news channels.","text":"AiYO, why tiger articles are getting more toxicnowadays like seeking alpha and motley fools.Flip prata from so many news channels.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607825628","repostId":"1197497046","repostType":4,"repost":{"id":"1197497046","kind":"news","pubTimestamp":1639526704,"share":"https://www.laohu8.com/m/news/1197497046?lang=&edition=full","pubTime":"2021-12-15 08:05","market":"sg","language":"en","title":"Renewed Selling Pressure Likely For Singapore Stock Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1197497046","media":"RTTNews","summary":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen mor","content":"<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.</p>\n<p>The global forecast for the Asian&nbsp;markets&nbsp;is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.</p>\n<p>The STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.</p>\n<p>For the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.</p>\n<p>Among the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.</p>\n<p>The lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.</p>\n<p>The Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&amp;P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.</p>\n<p>Concerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.</p>\n<p>Potentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.</p>\n<p>Lingering worries about the new Omicron variant of the&nbsp;coronavirus&nbsp;may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.</p>\n<p>Crude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.</p>\n<p>Closer to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Renewed Selling Pressure Likely For Singapore Stock Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRenewed Selling Pressure Likely For Singapore Stock Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau...</p>\n\n<a href=\"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197497046","content_text":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.\nThe global forecast for the Asian markets is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.\nThe STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.\nFor the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.\nThe lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.\nThe Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.\nConcerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.\nPotentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.\nLingering worries about the new Omicron variant of the coronavirus may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.\nCrude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.\nCloser to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.","news_type":1},"isVote":1,"tweetType":1,"viewCount":997,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604648763,"gmtCreate":1639393420656,"gmtModify":1639394148590,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"must come down first then can hoot.&nbsp;","listText":"must come down first then can hoot.&nbsp;","text":"must come down first then can hoot.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604648763","repostId":"2190677202","repostType":4,"repost":{"id":"2190677202","kind":"highlight","pubTimestamp":1639353437,"share":"https://www.laohu8.com/m/news/2190677202?lang=&edition=full","pubTime":"2021-12-13 07:57","market":"us","language":"en","title":"Tesla Stock: Headed to $1,580?","url":"https://stock-news.laohu8.com/highlight/detail?id=2190677202","media":"Motley Fool","summary":"One analyst thinks the electric-car maker's shares could rise 55% over the next 12 months.","content":"<p><b>Tesla</b> (NASDAQ:TSLA) has taken a hit recently. The stock has slid 16% since the beginning of November, even as the <b>S&amp;P 500</b> rose more than 2% over that same timeframe.</p>\n<p>But despite the stock's bearish trend recently, one analyst thinks the electric-car maker's shares will soar over the next 12 months. The analyst's updated price target for the stock calls for an impressive 55% upside from where shares closed on Friday. Based on Tesla's share count today, this implies a $1.6 trillion market capitalization.</p>\n<p>Here's why this analyst is so bullish.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/08e769c2d92397bfa34e2a502c09a26b\" tg-width=\"700\" tg-height=\"525\" referrerpolicy=\"no-referrer\"><span>Tesla factory. Image source: The Motley Fool.</span></p>\n<h2>55% upside?</h2>\n<p>Last Wednesday, New Street analyst and longtime Tesla bull Pierre Ferragu boosted his 12-month price target on Tesla stock from $1,290 to $1,580.</p>\n<p>Ferragu justifies his price target with a view for record fourth-quarter deliveries, impressive production rates at the company's factory in Shanghai, huge revenue growth next year, and more.</p>\n<p>Starting with Ferragu's estimates for Tesla's fourth-quarter deliveries, he says that the electric-car company's deliveries could come in as high as 280,000 to 285,000 in Q4. The midpoint of this range would imply 56% year-over-year growth and 17% sequential growth -- an impressive feat in a supply constrained environment. This would put total deliveries for the year at 910,000, or about 87% higher than last year.</p>\n<p>The analyst also thinks that Tesla's total revenue next year can approach $80 billion. This is about $9 billion higher than the current consensus analyst estimate calls for. Notably, Ferragu believes that Tesla is now producing electric vehicles at its factory in China at an annualized rate of more than 700,000 -- well above what Tesla initially said the factory would do. Adding this production to Tesla's factory in Fremont and the company's new factories in Texas and Germany will help sales soar next year, the analyst believes.</p>\n<h2>Valuation may be the biggest risk facing Tesla investors</h2>\n<p>But the riskiest part of this thesis may be Ferragu's view on the high valuation he believes Tesla stock will command. Ferragu thinks Tesla can trade at 50 to 100 times earnings for the foreseeable future. While the electric-car maker definitely deserves to trade at a multiple like this today, based on the company's strong growth prospects, there's always a chance that growth slows materially in the future. If growth does slow materially over the next five years, Tesla's price-to-earnings ratio could fall below Ferragu's target range.</p>\n<p>Further, investors should note that Tesla has a price-to-earnings ratio of over 300 today. So there's already huge growth priced in from the electric-car maker. Of course, analysts agree that earnings are about to soar. On average, analysts believe that Tesla's earnings per share will increase at an average annualized rate of 73% over the next five years.</p>\n<p>So while Tesla stock is looking more attractive after its recent sell-off, there are still risks to owning shares -- particularly when it comes to the stock's sky-high valuation. Tesla will need to keep executing extremely well over the long haul in order for its stock to be an outperformer from this level.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock: Headed to $1,580?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock: Headed to $1,580?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 07:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/12/tesla-stock-headed-to-1580/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla (NASDAQ:TSLA) has taken a hit recently. The stock has slid 16% since the beginning of November, even as the S&P 500 rose more than 2% over that same timeframe.\nBut despite the stock's bearish ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/12/tesla-stock-headed-to-1580/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4555":"新能源车","BK4099":"汽车制造商","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4534":"瑞士信贷持仓","TSLA":"特斯拉","BK4527":"明星科技股"},"source_url":"https://www.fool.com/investing/2021/12/12/tesla-stock-headed-to-1580/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190677202","content_text":"Tesla (NASDAQ:TSLA) has taken a hit recently. The stock has slid 16% since the beginning of November, even as the S&P 500 rose more than 2% over that same timeframe.\nBut despite the stock's bearish trend recently, one analyst thinks the electric-car maker's shares will soar over the next 12 months. The analyst's updated price target for the stock calls for an impressive 55% upside from where shares closed on Friday. Based on Tesla's share count today, this implies a $1.6 trillion market capitalization.\nHere's why this analyst is so bullish.\nTesla factory. Image source: The Motley Fool.\n55% upside?\nLast Wednesday, New Street analyst and longtime Tesla bull Pierre Ferragu boosted his 12-month price target on Tesla stock from $1,290 to $1,580.\nFerragu justifies his price target with a view for record fourth-quarter deliveries, impressive production rates at the company's factory in Shanghai, huge revenue growth next year, and more.\nStarting with Ferragu's estimates for Tesla's fourth-quarter deliveries, he says that the electric-car company's deliveries could come in as high as 280,000 to 285,000 in Q4. The midpoint of this range would imply 56% year-over-year growth and 17% sequential growth -- an impressive feat in a supply constrained environment. This would put total deliveries for the year at 910,000, or about 87% higher than last year.\nThe analyst also thinks that Tesla's total revenue next year can approach $80 billion. This is about $9 billion higher than the current consensus analyst estimate calls for. Notably, Ferragu believes that Tesla is now producing electric vehicles at its factory in China at an annualized rate of more than 700,000 -- well above what Tesla initially said the factory would do. Adding this production to Tesla's factory in Fremont and the company's new factories in Texas and Germany will help sales soar next year, the analyst believes.\nValuation may be the biggest risk facing Tesla investors\nBut the riskiest part of this thesis may be Ferragu's view on the high valuation he believes Tesla stock will command. Ferragu thinks Tesla can trade at 50 to 100 times earnings for the foreseeable future. While the electric-car maker definitely deserves to trade at a multiple like this today, based on the company's strong growth prospects, there's always a chance that growth slows materially in the future. If growth does slow materially over the next five years, Tesla's price-to-earnings ratio could fall below Ferragu's target range.\nFurther, investors should note that Tesla has a price-to-earnings ratio of over 300 today. So there's already huge growth priced in from the electric-car maker. Of course, analysts agree that earnings are about to soar. On average, analysts believe that Tesla's earnings per share will increase at an average annualized rate of 73% over the next five years.\nSo while Tesla stock is looking more attractive after its recent sell-off, there are still risks to owning shares -- particularly when it comes to the stock's sky-high valuation. Tesla will need to keep executing extremely well over the long haul in order for its stock to be an outperformer from this level.","news_type":1},"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604648551,"gmtCreate":1639393393793,"gmtModify":1639394148249,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"rollercoaster piece; sitting on bench","listText":"rollercoaster piece; sitting on bench","text":"rollercoaster piece; sitting on bench","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604648551","repostId":"1180589333","repostType":4,"repost":{"id":"1180589333","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639386147,"share":"https://www.laohu8.com/m/news/1180589333?lang=&edition=full","pubTime":"2021-12-13 17:02","market":"us","language":"en","title":"Lucid Group jumped nearly 10% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1180589333","media":"Tiger Newspress","summary":"Lucid Group jumped nearly 10% in premarket trading.The annual shakeup to the Nasdaq 100 stock-market","content":"<p>Lucid&nbsp;Group&nbsp;jumped&nbsp;nearly&nbsp;10%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/c270392b735802f59630183a86e034f6\" tg-width=\"775\" tg-height=\"552\" referrerpolicy=\"no-referrer\">The annual shakeup to the Nasdaq 100 stock-market index may open up slots for&nbsp;Lucid Group Inc.and&nbsp;Airbnb Inc.</p>\n<p>JPMorgan Chase &amp; Co.’s Min Moon, the bank’s head of equity index research and program trading strategy, said in a report that the two could be added to the closely watched tech-heavy benchmark late Friday, when the&nbsp;Nasdaq&nbsp;exchange will announce annual membership updates to account for changes in market capitalization. Such moves take effect after the close of trading on Dec. 17.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lucid Group jumped nearly 10% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLucid Group jumped nearly 10% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lucid&nbsp;Group&nbsp;jumped&nbsp;nearly&nbsp;10%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/c270392b735802f59630183a86e034f6\" tg-width=\"775\" tg-height=\"552\" referrerpolicy=\"no-referrer\">The annual shakeup to the Nasdaq 100 stock-market index may open up slots for&nbsp;Lucid Group Inc.and&nbsp;Airbnb Inc.</p>\n<p>JPMorgan Chase &amp; Co.’s Min Moon, the bank’s head of equity index research and program trading strategy, said in a report that the two could be added to the closely watched tech-heavy benchmark late Friday, when the&nbsp;Nasdaq&nbsp;exchange will announce annual membership updates to account for changes in market capitalization. Such moves take effect after the close of trading on Dec. 17.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180589333","content_text":"Lucid Group jumped nearly 10% in premarket trading.The annual shakeup to the Nasdaq 100 stock-market index may open up slots for Lucid Group Inc.and Airbnb Inc.\nJPMorgan Chase & Co.’s Min Moon, the bank’s head of equity index research and program trading strategy, said in a report that the two could be added to the closely watched tech-heavy benchmark late Friday, when the Nasdaq exchange will announce annual membership updates to account for changes in market capitalization. Such moves take effect after the close of trading on Dec. 17.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604648628,"gmtCreate":1639393360602,"gmtModify":1639395145155,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"finally its standing up shining like a star.","listText":"finally its standing up shining like a star.","text":"finally its standing up shining like a star.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604648628","repostId":"1199964643","repostType":4,"repost":{"id":"1199964643","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639387887,"share":"https://www.laohu8.com/m/news/1199964643?lang=&edition=full","pubTime":"2021-12-13 17:31","market":"us","language":"en","title":"Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra","url":"https://stock-news.laohu8.com/highlight/detail?id=1199964643","media":"Tiger Newspress","summary":"Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehe","content":"<p>Petros&nbsp;Pharmaceuticals&nbsp;soared&nbsp;nearly&nbsp;50%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;as&nbsp;it&nbsp;reported positive label comprehension results for Stendra.<img src=\"https://static.tigerbbs.com/7fb0701575bb0a522dfaad7f6d8c21b4\" tg-width=\"772\" tg-height=\"564\" width=\"100%\" height=\"auto\">The&nbsp;company&nbsp;reported positive over-the-counter (OTC) draft label comprehension study results for its erectile dysfunction (ED) Drug STENDRA®(avanafil).&nbsp; </p>\n<p>This Pivotal Label Comprehension Study was designed to assess comprehension of a draft STENDRA®Drug Facts Label intended for OTC use.&nbsp; This study was a key component in the Company's plans to engage in discussions with the FDA to expand the product's access through application for a possible OTC pathway.&nbsp; </p>\n<p>Early study indicators showed positive label comprehension outcomes in the study, which had encouraged the Company to initiate the next step, a Self-Selection Study, as it continued to build the case for the FDA for OTC access to STENDRA.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPetros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 17:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Petros&nbsp;Pharmaceuticals&nbsp;soared&nbsp;nearly&nbsp;50%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;as&nbsp;it&nbsp;reported positive label comprehension results for Stendra.<img src=\"https://static.tigerbbs.com/7fb0701575bb0a522dfaad7f6d8c21b4\" tg-width=\"772\" tg-height=\"564\" width=\"100%\" height=\"auto\">The&nbsp;company&nbsp;reported positive over-the-counter (OTC) draft label comprehension study results for its erectile dysfunction (ED) Drug STENDRA®(avanafil).&nbsp; </p>\n<p>This Pivotal Label Comprehension Study was designed to assess comprehension of a draft STENDRA®Drug Facts Label intended for OTC use.&nbsp; This study was a key component in the Company's plans to engage in discussions with the FDA to expand the product's access through application for a possible OTC pathway.&nbsp; </p>\n<p>Early study indicators showed positive label comprehension outcomes in the study, which had encouraged the Company to initiate the next step, a Self-Selection Study, as it continued to build the case for the FDA for OTC access to STENDRA.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199964643","content_text":"Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra.The company reported positive over-the-counter (OTC) draft label comprehension study results for its erectile dysfunction (ED) Drug STENDRA®(avanafil).  \nThis Pivotal Label Comprehension Study was designed to assess comprehension of a draft STENDRA®Drug Facts Label intended for OTC use.  This study was a key component in the Company's plans to engage in discussions with the FDA to expand the product's access through application for a possible OTC pathway.  \nEarly study indicators showed positive label comprehension outcomes in the study, which had encouraged the Company to initiate the next step, a Self-Selection Study, as it continued to build the case for the FDA for OTC access to STENDRA.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1002,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604648141,"gmtCreate":1639393336330,"gmtModify":1639394147844,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"CHPT a contrary sentiment; pull and push effect due to their quality.&nbsp; AMRS go go go!","listText":"CHPT a contrary sentiment; pull and push effect due to their quality.&nbsp; AMRS go go go!","text":"CHPT a contrary sentiment; pull and push effect due to their quality. AMRS go go go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604648141","repostId":"2190467769","repostType":4,"repost":{"id":"2190467769","kind":"highlight","pubTimestamp":1639367630,"share":"https://www.laohu8.com/m/news/2190467769?lang=&edition=full","pubTime":"2021-12-13 11:53","market":"us","language":"en","title":"3 Growth Stocks to Fuel Your 2022 Financial Freedom","url":"https://stock-news.laohu8.com/highlight/detail?id=2190467769","media":"Motley Fool","summary":"This basket of industrial and electric vehicle stocks is primed to pole vault your portfolio.","content":"<p>2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful for this year. However, those gains have come and gone. The challenge now is finding the best places to invest for 2022 and beyond.</p>\n<p><b>Corteva</b> (NYSE:CTVA), <b>Amyris</b> (NASDAQ:AMRS), and <b>ChargePoint Holdings</b> (NYSE:CHPT) are three growth stocks that could bring you closer to securing financial freedom. Here's what makes each a great buy now.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F656760%2Fgettyimages-1304258192.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Investor confidence is growing in the agriscience company</h2>\n<p><b>Lee Samaha (Corteva):</b> After a few years of questionable performance, it looks like Corteva is starting to realize the potential in its business. The company was created out of the DowDuPont merger and subsequent breakup. As such, it's the leading U.S. player in seed and crop protection, competing with international companies such as Monsanto owner <b>Bayer</b>, <b>BASF</b>, and <b>Syngenta</b>.</p>\n<p>The potential in the business lies in the expectation that Corteva can improve productivity and catch up to the kind of margins enjoyed by its peers. Among the ways it can enhance margin is by selling more of its products under its patents. This means Corteva will lower the share of revenue it pays in royalty costs to other companies, and Corteva's profit margin will go up.</p>\n<p>The good news is the company is making progress on all fronts. For example, management recently reaffirmed its target of $2.8 billion to $3.1 billion in adjusted earnings before interest, taxation, depreciation, and amortization (EBITDA) in 2022, rising from $2.5 billion to $2.6 billion in 2021. Moreover, management noted that the adoption rate of its Enlist (seed and crop protection) system was better than it had expected in 2021. In addition, there's a strong pipeline of other products under Corteva's patents coming through in the next few years.</p>\n<p>As such, a combination of mid-single-digit revenue growth and margin expansion promises to deliver double-digit earnings growth over the medium term for Corteva.</p>\n<h2>Supply chain woes knocked this stock down, but it's poised to get back up again</h2>\n<p><b>Scott Levine (Amyris): </b>Shares of synthetic biology specialist Amyris have both thrilled and devastated investors in 2021. While the stock skyrocketed more than 209% through the first three months of the year, it came back to earth in the second half -- particularly last month, when it fell 54%. Although it's the bears who are most interested in the stock at the moment, the company has several catalysts on the horizon in 2022 that could propel it considerably higher.</p>\n<p>One of the primary reasons for the stock's sell-off last month was concern related to supply chain headwinds facing Amyris and fear that they'd continue to plague the company in the coming months. But Amyris is working to shore up its supply chain, developing two facilities in Brazil and Nevada, both of which are expected to commence operations in the first half of 2022. According to John Melo, the company's CEO, the importance of the two facilities will have a material impact on its finances. On the company's third-quarter conference call, Melo said, \"These facilities will not only provide us much more resilience on the supply chain, they will also reduce our operating costs significantly and improve our gross margin by about 1,000 basis points.\"</p>\n<p>The company's growth, however, transcends an improvement in its gross margin as management forecasts revenue will rise to over $500 million in 2022 and $1 billion in 2023. For some perspective, Amyris reported $173 million on the top line in 2020, and it has booked sales of $357 million over the past 12 months. Looking toward the bottom of the income statement, investors can expect the company to report positive earnings before interest, taxes, depreciation, and amortization (EBITDA) -- a feat it last achieved in 2014.</p>\n<p>As companies look to source their products with sustainable ingredients, Amyris and its line of synbio-based products will likely become increasingly appealing. For forward-looking investors who have the patience to let this growth story play out, the stock's recent sell-off offers a great opportunity to pick up shares on the cheap, leaving more money available to splurge on presents for friends and loved ones.</p>\n<h2>This EV charging stock is off to the races</h2>\n<p><b>Daniel Foelber (ChargePoint Holdings): </b>America's largest electric vehicle (EV) charging infrastructure company, ChargePoint, reported third-quarter fiscal year 2022 earnings on Tuesday that exceeded expectations. After generating $65 million in revenue, ChargePoint now expects to earn between $73 million and $78 million in fourth-quarter revenue, bringing its full-year sales to between $235 million and $240 million. If it hits its target, ChargePoint would have grown its top line by 63% compared to last year. For context, consider that ChargePoint earned $146 million in revenue in fiscal year 2021 and $144.5 million in fiscal year 2020 revenue.</p>\n<p>The growth rate is impressive, but even if ChargePoint hits its revenue target it would still have a price-to-sales ratio of 28.7, which is more expensive than some of the market's hottest growth stocks. However, COVID-19 stunted its fiscal year 2021 growth and the company could now be off to the races now that EV investment is increasing. ChargePoint expects its rise to be directly proportional to the growth rate of U.S. passenger EV sales. Between 2020 to 2026, ChargePoint expects U.S. passenger EV sales to rise at a compound annual growth rate (CAGR) of 41% as more affordable EVs come on stream and consumer demand for EVs increases.</p>\n<p>Although still a long way from profitability, ChargePoint is an excellent catch-all way to expose your portfolio to the growth of EVs without having to risk picking a particular automaker to win out.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Growth Stocks to Fuel Your 2022 Financial Freedom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Growth Stocks to Fuel Your 2022 Financial Freedom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 11:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHPT":"ChargePoint Holdings Inc.","AMRS":"阿米瑞斯","BK4109":"特种化学制品","CAGR":"California Grapes International, Inc.","BK4542":"充电桩","BK4096":"电气部件与设备","CTVA":"Corteva, Inc.","BK4093":"化肥与农用药剂","BK4535":"淡马锡持仓","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190467769","content_text":"2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful for this year. However, those gains have come and gone. The challenge now is finding the best places to invest for 2022 and beyond.\nCorteva (NYSE:CTVA), Amyris (NASDAQ:AMRS), and ChargePoint Holdings (NYSE:CHPT) are three growth stocks that could bring you closer to securing financial freedom. Here's what makes each a great buy now.\nImage source: Getty Images.\nInvestor confidence is growing in the agriscience company\nLee Samaha (Corteva): After a few years of questionable performance, it looks like Corteva is starting to realize the potential in its business. The company was created out of the DowDuPont merger and subsequent breakup. As such, it's the leading U.S. player in seed and crop protection, competing with international companies such as Monsanto owner Bayer, BASF, and Syngenta.\nThe potential in the business lies in the expectation that Corteva can improve productivity and catch up to the kind of margins enjoyed by its peers. Among the ways it can enhance margin is by selling more of its products under its patents. This means Corteva will lower the share of revenue it pays in royalty costs to other companies, and Corteva's profit margin will go up.\nThe good news is the company is making progress on all fronts. For example, management recently reaffirmed its target of $2.8 billion to $3.1 billion in adjusted earnings before interest, taxation, depreciation, and amortization (EBITDA) in 2022, rising from $2.5 billion to $2.6 billion in 2021. Moreover, management noted that the adoption rate of its Enlist (seed and crop protection) system was better than it had expected in 2021. In addition, there's a strong pipeline of other products under Corteva's patents coming through in the next few years.\nAs such, a combination of mid-single-digit revenue growth and margin expansion promises to deliver double-digit earnings growth over the medium term for Corteva.\nSupply chain woes knocked this stock down, but it's poised to get back up again\nScott Levine (Amyris): Shares of synthetic biology specialist Amyris have both thrilled and devastated investors in 2021. While the stock skyrocketed more than 209% through the first three months of the year, it came back to earth in the second half -- particularly last month, when it fell 54%. Although it's the bears who are most interested in the stock at the moment, the company has several catalysts on the horizon in 2022 that could propel it considerably higher.\nOne of the primary reasons for the stock's sell-off last month was concern related to supply chain headwinds facing Amyris and fear that they'd continue to plague the company in the coming months. But Amyris is working to shore up its supply chain, developing two facilities in Brazil and Nevada, both of which are expected to commence operations in the first half of 2022. According to John Melo, the company's CEO, the importance of the two facilities will have a material impact on its finances. On the company's third-quarter conference call, Melo said, \"These facilities will not only provide us much more resilience on the supply chain, they will also reduce our operating costs significantly and improve our gross margin by about 1,000 basis points.\"\nThe company's growth, however, transcends an improvement in its gross margin as management forecasts revenue will rise to over $500 million in 2022 and $1 billion in 2023. For some perspective, Amyris reported $173 million on the top line in 2020, and it has booked sales of $357 million over the past 12 months. Looking toward the bottom of the income statement, investors can expect the company to report positive earnings before interest, taxes, depreciation, and amortization (EBITDA) -- a feat it last achieved in 2014.\nAs companies look to source their products with sustainable ingredients, Amyris and its line of synbio-based products will likely become increasingly appealing. For forward-looking investors who have the patience to let this growth story play out, the stock's recent sell-off offers a great opportunity to pick up shares on the cheap, leaving more money available to splurge on presents for friends and loved ones.\nThis EV charging stock is off to the races\nDaniel Foelber (ChargePoint Holdings): America's largest electric vehicle (EV) charging infrastructure company, ChargePoint, reported third-quarter fiscal year 2022 earnings on Tuesday that exceeded expectations. After generating $65 million in revenue, ChargePoint now expects to earn between $73 million and $78 million in fourth-quarter revenue, bringing its full-year sales to between $235 million and $240 million. If it hits its target, ChargePoint would have grown its top line by 63% compared to last year. For context, consider that ChargePoint earned $146 million in revenue in fiscal year 2021 and $144.5 million in fiscal year 2020 revenue.\nThe growth rate is impressive, but even if ChargePoint hits its revenue target it would still have a price-to-sales ratio of 28.7, which is more expensive than some of the market's hottest growth stocks. However, COVID-19 stunted its fiscal year 2021 growth and the company could now be off to the races now that EV investment is increasing. ChargePoint expects its rise to be directly proportional to the growth rate of U.S. passenger EV sales. Between 2020 to 2026, ChargePoint expects U.S. passenger EV sales to rise at a compound annual growth rate (CAGR) of 41% as more affordable EVs come on stream and consumer demand for EVs increases.\nAlthough still a long way from profitability, ChargePoint is an excellent catch-all way to expose your portfolio to the growth of EVs without having to risk picking a particular automaker to win out.","news_type":1},"isVote":1,"tweetType":1,"viewCount":789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602983156,"gmtCreate":1638956904520,"gmtModify":1638956937830,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"up &amp; down; undecided sentiments","listText":"up &amp; down; undecided sentiments","text":"up & down; undecided sentiments","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602983156","repostId":"1136716851","repostType":4,"repost":{"id":"1136716851","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638955203,"share":"https://www.laohu8.com/m/news/1136716851?lang=&edition=full","pubTime":"2021-12-08 17:20","market":"us","language":"en","title":"Some Vaccine stocks corrected in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1136716851","media":"Tiger Newspress","summary":"Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech SE,Moderna and Pfizer fell betwe","content":"<p>Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech&nbsp;SE,Moderna&nbsp;and&nbsp;Pfizer&nbsp;fell&nbsp;between 3% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/b5fc2db6a961be0363c3be880585ad0f\" tg-width=\"404\" tg-height=\"241\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some Vaccine stocks corrected in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome Vaccine stocks corrected in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 17:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech&nbsp;SE,Moderna&nbsp;and&nbsp;Pfizer&nbsp;fell&nbsp;between 3% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/b5fc2db6a961be0363c3be880585ad0f\" tg-width=\"404\" tg-height=\"241\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136716851","content_text":"Some Vaccine stocks corrected in premarket trading.Novavax,BioNTech SE,Moderna and Pfizer fell between 3% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606613030,"gmtCreate":1638869652302,"gmtModify":1638869652413,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"time to layer in; OVERSOLD by sentiments!","listText":"time to layer in; OVERSOLD by sentiments!","text":"time to layer in; OVERSOLD by sentiments!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606613030","repostId":"1151884429","repostType":4,"repost":{"id":"1151884429","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638868922,"share":"https://www.laohu8.com/m/news/1151884429?lang=&edition=full","pubTime":"2021-12-07 17:22","market":"us","language":"en","title":"Hot Chinese ADRs continued to rise in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1151884429","media":"Tiger Newspress","summary":"Hot Chinese ADRs continued to rise in premarket trading.Alibaba,JD.com,Pinduoduo,Baidu,NetEase,Nio,X","content":"<html><head></head><body><p>Hot Chinese ADRs continued to rise in premarket trading.Alibaba,JD.com,Pinduoduo,Baidu,NetEase,Nio,Xpeng Motors,Li Auto,DiDi Global,Bilibili and KE Holdings climbed between 2% and 5%.</p><p><img src=\"https://static.tigerbbs.com/b340dc1d1b4788055f15180e47c23cfb\" tg-width=\"404\" tg-height=\"664\" referrerpolicy=\"no-referrer\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hot Chinese ADRs continued to rise in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHot Chinese ADRs continued to rise in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-07 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Hot Chinese ADRs continued to rise in premarket trading.Alibaba,JD.com,Pinduoduo,Baidu,NetEase,Nio,Xpeng Motors,Li Auto,DiDi Global,Bilibili and KE Holdings climbed between 2% and 5%.</p><p><img src=\"https://static.tigerbbs.com/b340dc1d1b4788055f15180e47c23cfb\" tg-width=\"404\" tg-height=\"664\" referrerpolicy=\"no-referrer\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴","XPEV":"小鹏汽车","JD":"京东","BIDU":"百度","PDD":"拼多多","BEKE":"贝壳","NTES":"网易","BILI":"哔哩哔哩","LI":"理想汽车","NIO":"蔚来","DIDI":"滴滴(已退市)"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151884429","content_text":"Hot Chinese ADRs continued to rise in premarket trading.Alibaba,JD.com,Pinduoduo,Baidu,NetEase,Nio,Xpeng Motors,Li Auto,DiDi Global,Bilibili and KE Holdings climbed between 2% and 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":924,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601351149,"gmtCreate":1638493599691,"gmtModify":1638493599691,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"now this is getting interesting. Tonight chinese ADRs plunge?","listText":"now this is getting interesting. Tonight chinese ADRs plunge?","text":"now this is getting interesting. Tonight chinese ADRs plunge?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/601351149","repostId":"1101828151","repostType":4,"repost":{"id":"1101828151","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638493297,"share":"https://www.laohu8.com/m/news/1101828151?lang=&edition=full","pubTime":"2021-12-03 09:01","market":"hk","language":"en","title":"DIDI prepares to delist from U.S. stocks and to list in Hong Kong.","url":"https://stock-news.laohu8.com/highlight/detail?id=1101828151","media":"Tiger Newspress","summary":"DIDI prepares to delist from U.S. stocks and to list in Hong Kong.\nDiDi Global Inc. (NYSE: DIDI), th","content":"<p>DIDI&nbsp;prepares to delist from U.S. stocks and&nbsp;to list in Hong Kong.</p>\n<p>DiDi Global Inc. (NYSE: DIDI), the world’s leading mobility technology platform, today announced that its board of directors (the “Board”) has authorized and supports the Company to undertake the necessary procedures and file the relevant application(s) for the delisting of the Company’s ADSs from the New York Stock Exchange, while ensuring that ADSs will be convertible into freely tradable shares of the Company on another internationally recognized stock exchange at the election of ADS holders.</p>\n<p>The Company will organize a shareholders meeting to vote on the above matter at an appropriate time in the future, following necessary procedures. The Board has also authorized the Company to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DIDI prepares to delist from U.S. stocks and to list in Hong Kong.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDIDI prepares to delist from U.S. stocks and to list in Hong Kong.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 09:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DIDI&nbsp;prepares to delist from U.S. stocks and&nbsp;to list in Hong Kong.</p>\n<p>DiDi Global Inc. (NYSE: DIDI), the world’s leading mobility technology platform, today announced that its board of directors (the “Board”) has authorized and supports the Company to undertake the necessary procedures and file the relevant application(s) for the delisting of the Company’s ADSs from the New York Stock Exchange, while ensuring that ADSs will be convertible into freely tradable shares of the Company on another internationally recognized stock exchange at the election of ADS holders.</p>\n<p>The Company will organize a shareholders meeting to vote on the above matter at an appropriate time in the future, following necessary procedures. The Board has also authorized the Company to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIDI":"滴滴(已退市)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101828151","content_text":"DIDI prepares to delist from U.S. stocks and to list in Hong Kong.\nDiDi Global Inc. (NYSE: DIDI), the world’s leading mobility technology platform, today announced that its board of directors (the “Board”) has authorized and supports the Company to undertake the necessary procedures and file the relevant application(s) for the delisting of the Company’s ADSs from the New York Stock Exchange, while ensuring that ADSs will be convertible into freely tradable shares of the Company on another internationally recognized stock exchange at the election of ADS holders.\nThe Company will organize a shareholders meeting to vote on the above matter at an appropriate time in the future, following necessary procedures. The Board has also authorized the Company to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1001,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603242590,"gmtCreate":1638418589164,"gmtModify":1638418589268,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"Buy&nbsp;Pfizer, Moderna says theirs not that&nbsp;effective against new variant 🤣","listText":"Buy&nbsp;Pfizer, Moderna says theirs not that&nbsp;effective against new variant 🤣","text":"Buy Pfizer, Moderna says theirs not that effective against new variant 🤣","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603242590","repostId":"1119742422","repostType":4,"repost":{"id":"1119742422","kind":"news","pubTimestamp":1638368504,"share":"https://www.laohu8.com/m/news/1119742422?lang=&edition=full","pubTime":"2021-12-01 22:21","market":"us","language":"en","title":"Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?","url":"https://stock-news.laohu8.com/highlight/detail?id=1119742422","media":"TheStreet","summary":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks ","content":"<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p>\n<p>COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p>\n<p>The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p>\n<p>Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p>\n<p><b>Wall Street is neutral on Moderna</b></p>\n<p>Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p>\n<p>The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p>\n<p>Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p>\n<p><b>Pfizer: moderate buy, but experts are skeptical</b></p>\n<p>Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p>\n<p>JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p>\n<p>The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p>\n<p><b>Wall Street Memes’ take</b></p>\n<p>COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p>\n<p>Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p>\n<p>Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna or Pfizer Stock: Which to Buy as Omicron Spreads? </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna or Pfizer Stock: Which to Buy as Omicron Spreads? \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119742422","content_text":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.\nThe stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.\nFigure 1: SPY, MRNA and PFE performance in the past 5-trading days.\nBetween two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?\nWall Street is neutral on Moderna\nModerna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.\nThe most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.\nMorgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.\nPfizer: moderate buy, but experts are skeptical\nWall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.\nJPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.\nThe most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.\nWall Street Memes’ take\nCOVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.\nFigure 2: MRNA and PFE performance in the past 5-years.\nPfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.\nDue to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.","news_type":1},"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872895223,"gmtCreate":1637468757636,"gmtModify":1637468757636,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"unexpected bonus of a pullback; get ready for an early christmas discount","listText":"unexpected bonus of a pullback; get ready for an early christmas discount","text":"unexpected bonus of a pullback; get ready for an early christmas discount","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872895223","repostId":"1114542201","repostType":4,"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871357134,"gmtCreate":1637029139361,"gmtModify":1637029181810,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"legalize it than having it grown into a huge dark market","listText":"legalize it than having it grown into a huge dark market","text":"legalize it than having it grown into a huge dark market","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871357134","repostId":"1176797738","repostType":2,"isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879842872,"gmtCreate":1636709154456,"gmtModify":1636709154456,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"the sector that have been greatly neglect. Same goes on $TLRY - give them a bit of time and they'll shine.","listText":"the sector that have been greatly neglect. Same goes on $TLRY - give them a bit of time and they'll shine.","text":"the sector that have been greatly neglect. Same goes on $TLRY - give them a bit of time and they'll shine.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879842872","repostId":"1111257324","repostType":4,"repost":{"id":"1111257324","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636707678,"share":"https://www.laohu8.com/m/news/1111257324?lang=&edition=full","pubTime":"2021-11-12 17:01","market":"us","language":"en","title":"Sundial Growers shares jumped nearly 30% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1111257324","media":"Tiger Newspress","summary":"Sundial Growers shares jumped nearly 30% in premarket trading.\nSundial Growers Q3 net earnings of C$","content":"<p>Sundial&nbsp;Growers&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;30%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3de04b90c63ee97eeb257d4958dd89eb\" tg-width=\"876\" tg-height=\"655\" referrerpolicy=\"no-referrer\"></p>\n<p>Sundial Growers&nbsp;Q3 net earnings of C$11.3M vs. a loss of C$71.4M in prior year.</p>\n<p>In addition, Sundial Growers'&nbsp;Board has approved a new share repurchase program of up to C$100 million of its outstanding common shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sundial Growers shares jumped nearly 30% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSundial Growers shares jumped nearly 30% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-12 17:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sundial&nbsp;Growers&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;30%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3de04b90c63ee97eeb257d4958dd89eb\" tg-width=\"876\" tg-height=\"655\" referrerpolicy=\"no-referrer\"></p>\n<p>Sundial Growers&nbsp;Q3 net earnings of C$11.3M vs. a loss of C$71.4M in prior year.</p>\n<p>In addition, Sundial Growers'&nbsp;Board has approved a new share repurchase program of up to C$100 million of its outstanding common shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNDL":"SNDL Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111257324","content_text":"Sundial Growers shares jumped nearly 30% in premarket trading.\nSundial Growers Q3 net earnings of C$11.3M vs. a loss of C$71.4M in prior year.\nIn addition, Sundial Growers' Board has approved a new share repurchase program of up to C$100 million of its outstanding common shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879842916,"gmtCreate":1636709113621,"gmtModify":1636709113621,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"another missed expectations. all hyped.","listText":"another missed expectations. all hyped.","text":"another missed expectations. all hyped.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879842916","repostId":"1124567274","repostType":4,"repost":{"id":"1124567274","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636707952,"share":"https://www.laohu8.com/m/news/1124567274?lang=&edition=full","pubTime":"2021-11-12 17:05","market":"us","language":"en","title":"Lordstown Motors shares fell 10.6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1124567274","media":"Tiger Newspress","summary":"Lordstown Motors shares fell 10.6% in premarket trading.\n\nLordstown Motors Corp on Thursday delayed ","content":"<p>Lordstown&nbsp;Motors&nbsp;shares&nbsp;fell&nbsp;10.6%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/fc7079e6f893c9c350e0638b20f83d0d\" tg-width=\"875\" tg-height=\"609\" referrerpolicy=\"no-referrer\"></p>\n<p>Lordstown Motors Corp on Thursday delayed next year's launch of its Endurance electric pickup truck by a quarter, citing parts and materials shortages and other supply-chain issues.</p>\n<p>A day after announcing it had finalized a deal for Taiwan's Foxconn Technology Co Ltd to buy Lordstown's plant in northeast Ohio for $230 million and take over production of the Endurance, Lordstown said on Thursday it also signed a memorandum of understanding with Cox Automotive.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lordstown Motors shares fell 10.6% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLordstown Motors shares fell 10.6% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-12 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lordstown&nbsp;Motors&nbsp;shares&nbsp;fell&nbsp;10.6%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/fc7079e6f893c9c350e0638b20f83d0d\" tg-width=\"875\" tg-height=\"609\" referrerpolicy=\"no-referrer\"></p>\n<p>Lordstown Motors Corp on Thursday delayed next year's launch of its Endurance electric pickup truck by a quarter, citing parts and materials shortages and other supply-chain issues.</p>\n<p>A day after announcing it had finalized a deal for Taiwan's Foxconn Technology Co Ltd to buy Lordstown's plant in northeast Ohio for $230 million and take over production of the Endurance, Lordstown said on Thursday it also signed a memorandum of understanding with Cox Automotive.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124567274","content_text":"Lordstown Motors shares fell 10.6% in premarket trading.\n\nLordstown Motors Corp on Thursday delayed next year's launch of its Endurance electric pickup truck by a quarter, citing parts and materials shortages and other supply-chain issues.\nA day after announcing it had finalized a deal for Taiwan's Foxconn Technology Co Ltd to buy Lordstown's plant in northeast Ohio for $230 million and take over production of the Endurance, Lordstown said on Thursday it also signed a memorandum of understanding with Cox Automotive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879846294,"gmtCreate":1636709076556,"gmtModify":1636709076556,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"all the expectations missed.","listText":"all the expectations missed.","text":"all the expectations missed.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/879846294","repostId":"1141156484","repostType":4,"isVote":1,"tweetType":1,"viewCount":488,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":815834802,"gmtCreate":1630664153206,"gmtModify":1631887192604,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>It's almost time to average in at current price levels. &nbsp;Baby steps at a time, go easy. &nbsp;[YoYo]&nbsp;[Call]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>It's almost time to average in at current price levels. &nbsp;Baby steps at a time, go easy. &nbsp;[YoYo]&nbsp;[Call]&nbsp;","text":"$Cassava Sciences Inc(SAVA)$It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/815834802","isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819437902,"gmtCreate":1630085057706,"gmtModify":1704955808226,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>Lunch break isover, time to go GREEN![Smart]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>Lunch break isover, time to go GREEN![Smart]&nbsp;","text":"$Cassava Sciences Inc(SAVA)$Lunch break isover, time to go GREEN![Smart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819437902","isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819544328,"gmtCreate":1630080347364,"gmtModify":1704955748871,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> SQUEEZE the BEARS!!!","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> SQUEEZE the BEARS!!!","text":"$Cassava Sciences Inc(SAVA)$ SQUEEZE the BEARS!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819544328","isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819524151,"gmtCreate":1630079037573,"gmtModify":1704955718546,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","text":"$Cassava Sciences Inc(SAVA)$ Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819524151","isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":879846294,"gmtCreate":1636709076556,"gmtModify":1636709076556,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"all the expectations missed.","listText":"all the expectations missed.","text":"all the expectations missed.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/879846294","repostId":"1141156484","repostType":4,"repost":{"id":"1141156484","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636708414,"share":"https://www.laohu8.com/m/news/1141156484?lang=&edition=full","pubTime":"2021-11-12 17:13","market":"us","language":"en","title":"AstraZeneca shares fell nearly 3% as its third-quarter earnings missed expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1141156484","media":"Tiger Newspress","summary":"AstraZeneca shares fell nearly 3% in premarket trading.Total revenue jumped 47% to $9.74 billion for","content":"<p>AstraZeneca&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;3%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/e10a51f0e7b10fda2b988cb5a3967b60\" tg-width=\"877\" tg-height=\"614\" referrerpolicy=\"no-referrer\">Total revenue jumped 47% to $9.74 billion for the three months to September on a constant-currency basis, while core earnings came in at $1.08 per share, the company said.</p>\n<p>Analysts on average were expecting profit of $1.28 per share on sales of $9.4 billion, according to Refinitiv IBES data.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca shares fell nearly 3% as its third-quarter earnings missed expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca shares fell nearly 3% as its third-quarter earnings missed expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-12 17:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AstraZeneca&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;3%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/e10a51f0e7b10fda2b988cb5a3967b60\" tg-width=\"877\" tg-height=\"614\" referrerpolicy=\"no-referrer\">Total revenue jumped 47% to $9.74 billion for the three months to September on a constant-currency basis, while core earnings came in at $1.08 per share, the company said.</p>\n<p>Analysts on average were expecting profit of $1.28 per share on sales of $9.4 billion, according to Refinitiv IBES data.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141156484","content_text":"AstraZeneca shares fell nearly 3% in premarket trading.Total revenue jumped 47% to $9.74 billion for the three months to September on a constant-currency basis, while core earnings came in at $1.08 per share, the company said.\nAnalysts on average were expecting profit of $1.28 per share on sales of $9.4 billion, according to Refinitiv IBES data.","news_type":1},"isVote":1,"tweetType":1,"viewCount":488,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":109878404,"gmtCreate":1619686563408,"gmtModify":1631886267689,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a> have put this ticker in storage; will look back on it months later :O","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CTRM\">$Castor Maritime, Inc.(CTRM)$</a> have put this ticker in storage; will look back on it months later :O","text":"$Castor Maritime, Inc.(CTRM)$ have put this ticker in storage; will look back on it months later :O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/109878404","isVote":1,"tweetType":1,"viewCount":858,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":601351149,"gmtCreate":1638493599691,"gmtModify":1638493599691,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"now this is getting interesting. Tonight chinese ADRs plunge?","listText":"now this is getting interesting. Tonight chinese ADRs plunge?","text":"now this is getting interesting. Tonight chinese ADRs plunge?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/601351149","repostId":"1101828151","repostType":4,"repost":{"id":"1101828151","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638493297,"share":"https://www.laohu8.com/m/news/1101828151?lang=&edition=full","pubTime":"2021-12-03 09:01","market":"hk","language":"en","title":"DIDI prepares to delist from U.S. stocks and to list in Hong Kong.","url":"https://stock-news.laohu8.com/highlight/detail?id=1101828151","media":"Tiger Newspress","summary":"DIDI prepares to delist from U.S. stocks and to list in Hong Kong.\nDiDi Global Inc. (NYSE: DIDI), th","content":"<p>DIDI&nbsp;prepares to delist from U.S. stocks and&nbsp;to list in Hong Kong.</p>\n<p>DiDi Global Inc. (NYSE: DIDI), the world’s leading mobility technology platform, today announced that its board of directors (the “Board”) has authorized and supports the Company to undertake the necessary procedures and file the relevant application(s) for the delisting of the Company’s ADSs from the New York Stock Exchange, while ensuring that ADSs will be convertible into freely tradable shares of the Company on another internationally recognized stock exchange at the election of ADS holders.</p>\n<p>The Company will organize a shareholders meeting to vote on the above matter at an appropriate time in the future, following necessary procedures. The Board has also authorized the Company to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DIDI prepares to delist from U.S. stocks and to list in Hong Kong.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDIDI prepares to delist from U.S. stocks and to list in Hong Kong.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 09:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DIDI&nbsp;prepares to delist from U.S. stocks and&nbsp;to list in Hong Kong.</p>\n<p>DiDi Global Inc. (NYSE: DIDI), the world’s leading mobility technology platform, today announced that its board of directors (the “Board”) has authorized and supports the Company to undertake the necessary procedures and file the relevant application(s) for the delisting of the Company’s ADSs from the New York Stock Exchange, while ensuring that ADSs will be convertible into freely tradable shares of the Company on another internationally recognized stock exchange at the election of ADS holders.</p>\n<p>The Company will organize a shareholders meeting to vote on the above matter at an appropriate time in the future, following necessary procedures. The Board has also authorized the Company to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIDI":"滴滴(已退市)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101828151","content_text":"DIDI prepares to delist from U.S. stocks and to list in Hong Kong.\nDiDi Global Inc. (NYSE: DIDI), the world’s leading mobility technology platform, today announced that its board of directors (the “Board”) has authorized and supports the Company to undertake the necessary procedures and file the relevant application(s) for the delisting of the Company’s ADSs from the New York Stock Exchange, while ensuring that ADSs will be convertible into freely tradable shares of the Company on another internationally recognized stock exchange at the election of ADS holders.\nThe Company will organize a shareholders meeting to vote on the above matter at an appropriate time in the future, following necessary procedures. The Board has also authorized the Company to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1001,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872895223,"gmtCreate":1637468757636,"gmtModify":1637468757636,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"unexpected bonus of a pullback; get ready for an early christmas discount","listText":"unexpected bonus of a pullback; get ready for an early christmas discount","text":"unexpected bonus of a pullback; get ready for an early christmas discount","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872895223","repostId":"1114542201","repostType":4,"repost":{"id":"1114542201","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637335740,"share":"https://www.laohu8.com/m/news/1114542201?lang=&edition=full","pubTime":"2021-11-19 23:29","market":"us","language":"en","title":"Boeing Dreamliner Defects Bog Down Production","url":"https://stock-news.laohu8.com/highlight/detail?id=1114542201","media":"Tiger Newspress","summary":"Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.\n\nBoein","content":"<p>Boeing stock dropped 4% in morning trading&nbsp;as&nbsp;Boeing Dreamliner defected bog down production.</p>\n<p><img src=\"https://static.tigerbbs.com/3c6c1e62a6a6a253da601f54af830508\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Boeing&nbsp;Co.&nbsp;has further slowed production of 787 Dreamliners as&nbsp;it addresses defects&nbsp;that&nbsp;are delaying deliveries of new jets&nbsp;and complicating airlines’ plans, people familiar with the matter said.</p>\n<p>The plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.</p>\n<p>The latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.</p>\n<p>A string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.</p>\n<p>A Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.</p>\n<p>Boeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.</p>\n<p>The company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.</p>\n<p>“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.</p>\n<p>In an Oct. 27 call with analysts, Chief Executive David Calhoun said&nbsp;defective titanium parts&nbsp;were the “long pole in the tent” among remaining production problems to address.</p>\n<p>The door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing&nbsp;has largely been dealing with tiny gaps&nbsp;where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.</p>\n<p>The Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.</p>\n<p>None of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.</p>\n<p>With deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.</p>\n<p>The delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.</p>\n<p>American Airlines Group&nbsp;Inc.&nbsp;said it had trimmed its flying plans due to the delayed arrival of its new 787s.</p>\n<p>“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.</p>\n<p>The FAA launched a broad review of Boeing’s Dreamliner production in late 2020.</p>\n<p>On Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.</p>\n<p>Representatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boeing Dreamliner Defects Bog Down Production</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoeing Dreamliner Defects Bog Down Production\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 23:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Boeing stock dropped 4% in morning trading&nbsp;as&nbsp;Boeing Dreamliner defected bog down production.</p>\n<p><img src=\"https://static.tigerbbs.com/3c6c1e62a6a6a253da601f54af830508\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Boeing&nbsp;Co.&nbsp;has further slowed production of 787 Dreamliners as&nbsp;it addresses defects&nbsp;that&nbsp;are delaying deliveries of new jets&nbsp;and complicating airlines’ plans, people familiar with the matter said.</p>\n<p>The plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.</p>\n<p>The latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.</p>\n<p>A string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.</p>\n<p>A Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.</p>\n<p>Boeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.</p>\n<p>The company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.</p>\n<p>“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.</p>\n<p>In an Oct. 27 call with analysts, Chief Executive David Calhoun said&nbsp;defective titanium parts&nbsp;were the “long pole in the tent” among remaining production problems to address.</p>\n<p>The door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing&nbsp;has largely been dealing with tiny gaps&nbsp;where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.</p>\n<p>The Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.</p>\n<p>None of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.</p>\n<p>With deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.</p>\n<p>The delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.</p>\n<p>American Airlines Group&nbsp;Inc.&nbsp;said it had trimmed its flying plans due to the delayed arrival of its new 787s.</p>\n<p>“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.</p>\n<p>The FAA launched a broad review of Boeing’s Dreamliner production in late 2020.</p>\n<p>On Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.</p>\n<p>Representatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114542201","content_text":"Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.\n\nBoeing Co. has further slowed production of 787 Dreamliners as it addresses defects that are delaying deliveries of new jets and complicating airlines’ plans, people familiar with the matter said.\nThe plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.\nThe latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.\nA string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.\nA Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.\nBoeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.\nThe company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.\n“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.\nIn an Oct. 27 call with analysts, Chief Executive David Calhoun said defective titanium parts were the “long pole in the tent” among remaining production problems to address.\nThe door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing has largely been dealing with tiny gaps where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.\nThe Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.\nNone of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.\nWith deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.\nThe delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.\nAmerican Airlines Group Inc. said it had trimmed its flying plans due to the delayed arrival of its new 787s.\n“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.\nThe FAA launched a broad review of Boeing’s Dreamliner production in late 2020.\nOn Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.\nRepresentatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602983156,"gmtCreate":1638956904520,"gmtModify":1638956937830,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"up &amp; down; undecided sentiments","listText":"up &amp; down; undecided sentiments","text":"up & down; undecided sentiments","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602983156","repostId":"1136716851","repostType":4,"isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879842916,"gmtCreate":1636709113621,"gmtModify":1636709113621,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"another missed expectations. all hyped.","listText":"another missed expectations. all hyped.","text":"another missed expectations. all hyped.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879842916","repostId":"1124567274","repostType":4,"repost":{"id":"1124567274","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636707952,"share":"https://www.laohu8.com/m/news/1124567274?lang=&edition=full","pubTime":"2021-11-12 17:05","market":"us","language":"en","title":"Lordstown Motors shares fell 10.6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1124567274","media":"Tiger Newspress","summary":"Lordstown Motors shares fell 10.6% in premarket trading.\n\nLordstown Motors Corp on Thursday delayed ","content":"<p>Lordstown&nbsp;Motors&nbsp;shares&nbsp;fell&nbsp;10.6%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/fc7079e6f893c9c350e0638b20f83d0d\" tg-width=\"875\" tg-height=\"609\" referrerpolicy=\"no-referrer\"></p>\n<p>Lordstown Motors Corp on Thursday delayed next year's launch of its Endurance electric pickup truck by a quarter, citing parts and materials shortages and other supply-chain issues.</p>\n<p>A day after announcing it had finalized a deal for Taiwan's Foxconn Technology Co Ltd to buy Lordstown's plant in northeast Ohio for $230 million and take over production of the Endurance, Lordstown said on Thursday it also signed a memorandum of understanding with Cox Automotive.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lordstown Motors shares fell 10.6% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLordstown Motors shares fell 10.6% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-12 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lordstown&nbsp;Motors&nbsp;shares&nbsp;fell&nbsp;10.6%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/fc7079e6f893c9c350e0638b20f83d0d\" tg-width=\"875\" tg-height=\"609\" referrerpolicy=\"no-referrer\"></p>\n<p>Lordstown Motors Corp on Thursday delayed next year's launch of its Endurance electric pickup truck by a quarter, citing parts and materials shortages and other supply-chain issues.</p>\n<p>A day after announcing it had finalized a deal for Taiwan's Foxconn Technology Co Ltd to buy Lordstown's plant in northeast Ohio for $230 million and take over production of the Endurance, Lordstown said on Thursday it also signed a memorandum of understanding with Cox Automotive.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124567274","content_text":"Lordstown Motors shares fell 10.6% in premarket trading.\n\nLordstown Motors Corp on Thursday delayed next year's launch of its Endurance electric pickup truck by a quarter, citing parts and materials shortages and other supply-chain issues.\nA day after announcing it had finalized a deal for Taiwan's Foxconn Technology Co Ltd to buy Lordstown's plant in northeast Ohio for $230 million and take over production of the Endurance, Lordstown said on Thursday it also signed a memorandum of understanding with Cox Automotive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":819544328,"gmtCreate":1630080347364,"gmtModify":1704955748871,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> SQUEEZE the BEARS!!!","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> SQUEEZE the BEARS!!!","text":"$Cassava Sciences Inc(SAVA)$ SQUEEZE the BEARS!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819544328","isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":879842872,"gmtCreate":1636709154456,"gmtModify":1636709154456,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"the sector that have been greatly neglect. Same goes on $TLRY - give them a bit of time and they'll shine.","listText":"the sector that have been greatly neglect. Same goes on $TLRY - give them a bit of time and they'll shine.","text":"the sector that have been greatly neglect. Same goes on $TLRY - give them a bit of time and they'll shine.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879842872","repostId":"1111257324","repostType":4,"repost":{"id":"1111257324","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636707678,"share":"https://www.laohu8.com/m/news/1111257324?lang=&edition=full","pubTime":"2021-11-12 17:01","market":"us","language":"en","title":"Sundial Growers shares jumped nearly 30% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1111257324","media":"Tiger Newspress","summary":"Sundial Growers shares jumped nearly 30% in premarket trading.\nSundial Growers Q3 net earnings of C$","content":"<p>Sundial&nbsp;Growers&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;30%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3de04b90c63ee97eeb257d4958dd89eb\" tg-width=\"876\" tg-height=\"655\" referrerpolicy=\"no-referrer\"></p>\n<p>Sundial Growers&nbsp;Q3 net earnings of C$11.3M vs. a loss of C$71.4M in prior year.</p>\n<p>In addition, Sundial Growers'&nbsp;Board has approved a new share repurchase program of up to C$100 million of its outstanding common shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sundial Growers shares jumped nearly 30% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSundial Growers shares jumped nearly 30% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-12 17:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sundial&nbsp;Growers&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;30%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3de04b90c63ee97eeb257d4958dd89eb\" tg-width=\"876\" tg-height=\"655\" referrerpolicy=\"no-referrer\"></p>\n<p>Sundial Growers&nbsp;Q3 net earnings of C$11.3M vs. a loss of C$71.4M in prior year.</p>\n<p>In addition, Sundial Growers'&nbsp;Board has approved a new share repurchase program of up to C$100 million of its outstanding common shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNDL":"SNDL Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111257324","content_text":"Sundial Growers shares jumped nearly 30% in premarket trading.\nSundial Growers Q3 net earnings of C$11.3M vs. a loss of C$71.4M in prior year.\nIn addition, Sundial Growers' Board has approved a new share repurchase program of up to C$100 million of its outstanding common shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606613030,"gmtCreate":1638869652302,"gmtModify":1638869652413,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"time to layer in; OVERSOLD by sentiments!","listText":"time to layer in; OVERSOLD by sentiments!","text":"time to layer in; OVERSOLD by sentiments!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606613030","repostId":"1151884429","repostType":4,"isVote":1,"tweetType":1,"viewCount":924,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603242590,"gmtCreate":1638418589164,"gmtModify":1638418589268,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"Buy&nbsp;Pfizer, Moderna says theirs not that&nbsp;effective against new variant 🤣","listText":"Buy&nbsp;Pfizer, Moderna says theirs not that&nbsp;effective against new variant 🤣","text":"Buy Pfizer, Moderna says theirs not that effective against new variant 🤣","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603242590","repostId":"1119742422","repostType":4,"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692038090,"gmtCreate":1640789614349,"gmtModify":1640789614445,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"is this author a paid FUDster?","listText":"is this author a paid FUDster?","text":"is this author a paid FUDster?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692038090","repostId":"2195545489","repostType":2,"repost":{"id":"2195545489","kind":"highlight","pubTimestamp":1640780993,"share":"https://www.laohu8.com/m/news/2195545489?lang=&edition=full","pubTime":"2021-12-29 20:29","market":"us","language":"en","title":"5 Stocks I'd Sell Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2195545489","media":"Motley Fool","summary":"These could be some of the worst-performing and riskiest investments in 2022.","content":"<html><head></head><body><p>For many investors, the New Year is a time of reflection. They&#39;re thinking about what trends they want to buy into for the upcoming year and what stocks might help make them rich.</p><p>However, reflection is a two-way street. Just as there are great companies that can make investors wealthy, there are stocks that could cost investors a lot of money and should be avoided at all costs. Below are five stocks investors should consider selling right now.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9a8aaeae4465770036314f05da71f414\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>AMC Entertainment</h2><p>It&#39;s no secret that I believe movie theater chain <b>AMC Entertainment</b> (NYSE:AMC) is the most overvalued stock on Wall Street.</p><p>For those of you who may not have followed the AMC &#34;made for TV drama&#34; that&#39;s occurred this year, the company&#39;s shares are up more than 1,200% following an epic short squeeze earlier this year. Short-sellers (investors betting on a security&#39;s price to decline) were caught off-guard when AMC was able to save itself from imminent bankruptcy by selling 164 million shares of stock and issuing high-interest debt. But with this short squeeze now in the rearview mirror, AMC&#39;s abysmal operating performance, bloated balance sheet, and declining bargaining power with movie studios are in plain view.</p><p>For example, before the pandemic took effect, AMC was regularly securing theatrical exclusivity deals of 75 to 90 days. Nowadays, AMC is lucky to secure 45-day theatrical exclusivity. Even taking into account that most revenue is picked up in the first couple of weeks, this 30- to 45-day reduction in exclusivity is going to pinch AMC. It&#39;s also bad news considering that inflation-adjusted domestic box office sales have been in decline since 2002.</p><p>The bigger issue, as I&#39;ve stated over and over, is AMC can&#39;t make good on its liabilities. It has $5.45 billion in outstanding debt at roughly an 8% average interest rate. Keep that rate in mind, because lending rates are pretty much at historic lows. It also has over $1 billion in aggregate debt due in late 2026 and mid-2027 that&#39;s valued at more than 30% below face value. With the company hemorrhaging cash and not able to sell any additional stock thanks to its impassioned but misguided retail investors, it looks to be making a slow walk toward a chapter 11 bankruptcy reorganization.</p><p>Suffice it to say, AMC Entertainment is a stock investors can confidently sell right now.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b45c4bd410befdb22fd801c7758dfb71\" tg-width=\"700\" tg-height=\"525\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>MicroStrategy</h2><p>A second stock investors should strongly consider selling right now is &#34;enterprise analytics software company&#34; <b>MicroStrategy</b> (NASDAQ:MSTR). I have &#34;enterprise analytics software company&#34; in quotations because CEO Michael Saylor has effectively ignored this stagnant part of the company&#39;s operations and turned MicroStrategy into a leveraged gamble on <b>Bitcoin</b> (CRYPTO:BTC).</p><p>According to the company&#39;s investor presentation earlier this month, it&#39;s holding 122,478 Bitcoin at an average price of $29,861.  The issue with this strategy is threefold, in my view.</p><p>First, I&#39;m not convinced Bitcoin is a sound investment. I recently outlined my views on Bitcoin, which centers on its false scarcity and it&#39;s less-than-stellar network performance. Bitcoin is constantly being out-innovated when it comes to payments and nonfinancial blockchain applications.</p><p>Second, MicroStrategy destroyed a reasonably safe balance sheet by piling on more than $2 billion in debt and issuing $900 million in stock, all of which was used to buy Bitcoin. Saylor has leveraged a public company&#39;s future on an asset that produces nothing.</p><p>And third, I believe Saylor is a poor leader. Earlier this year, Saylor told the world in an interview to &#34;go mortgage your house and buy Bitcoin with it.&#34; This is <i>incredibly</i> <i>bad</i> <i>advice</i>, and all the more reason to avoid MicroStrategy.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0a442339ef77177eb97fecfa070c7ac0\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>Cassava Sciences</h2><p>Another stock investors can sell right now is clinical-stage biotech stock <b>Cassava Sciences</b> (NASDAQ:SAVA).</p><p>Cassava made waves in the first quarter when it announced positive interim analysis data from its open-label study of simufilam for patients with Alzheimer&#39;s disease. The data showed both cognition and behavior score improvements at the six-month mark. Since Alzheimer&#39;s has no cure, any positive clinical data tends to be well-received.</p><p>But there are two glaring issues that should send folks scurrying to the sidelines. First of all, the track record of success for clinical-stage therapeutics targeting Alzheimer&#39;s disease is incredibly low. While we&#39;ve witnessed plenty of early stage success, virtually all late-stage Alzheimer&#39;s trials end in failure. This isn&#39;t a knock against the research, so much as recognizing that tackling the blood-brain barrier is tricky.</p><p>The second concern is that Cassava Sciences is facing allegations of manipulating its trial data. The company also announced in November that federal agencies are investigating its practices, without specifically naming the federal agencies in question. Keeping in mind that some of the allegations have come from firms shorting the stock, this is a headache you&#39;re better off letting someone else deal with.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b3b1defb6dba4980112c9a56af41a57c\" tg-width=\"700\" tg-height=\"393\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>GameStop</h2><p>Investors should also considering selling the original meme stock, <b>GameStop</b> (NYSE:GME).</p><p>A few weeks before AMC ascended to the heavens on its short squeeze, GameStop&#39;s high short interest attracted retail investors. In fact, GameStop&#39;s short interest was higher than any publicly traded company, as of mid-January, making it the perfect candidate for an epic squeeze. However, with this short-term event now over, investors are forced to grapple with GameStop&#39;s poor operating performance.</p><p>On the positive side, GameStop was able to raise sufficient capital from selling its stock to rid its balance sheet of debt. This net-cash position, coupled with the long-term growth potential of digital gaming, means there are no bankruptcy concerns, unlike with AMC.</p><p>But GameStop was notably late in shifting its strategy to include digital gaming. Nowadays, the company is busy shuttering stores in an effort to lower its expenses and back its way into the profit column. The company&#39;s large brick-and-mortar presence is expected to work against it for the foreseeable future, and could keep it from profitability for a few years.</p><p>Further, Wall Street has been unimpressed with management&#39;s lack of concrete steps that&#39;ll be taken to turn the business around. Even with a hefty cash balance, GameStop is grossly overvalued.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2bd808070a9dde55f37210b59edc2e23\" tg-width=\"700\" tg-height=\"393\" width=\"100%\" height=\"auto\"/><span>A Tesla Model S charging. Image source: Tesla Motors.</span></p><h2>Tesla Motors</h2><p>Last, but certainly not least, investors should consider giving electric vehicle (EV) manufacturer <b>Tesla Motors</b> (NASDAQ:TSLA) the boot.</p><p>Tesla has managed to do a lot of great things with its first-mover advantage. The company is on pace to deliver more than 800,000 EVs in 2021, and CEO Elon Musk has watched his company deliver its two largest operating profits since inception this year. The range, capacity, and power associated with Tesla&#39;s batteries has been superior as well.</p><p>Yet, these competitive advantages are unlikely to last given that all of the world&#39;s largest auto companies are throwing billions of dollars at EV research. For instance, <b>General Motors</b> and <b>Ford Motor Company</b> are respectively investing $35 billion and $30 billion in next-generation automobiles, with both companies bringing 30 new EVs to market by 2025. Tesla&#39;s first-mover advantage will fade sooner than later.</p><p>What&#39;s more, Tesla&#39;s income statement has been aided by selling Bitcoin at a profit earlier this year, as well as selling renewable energy credits (RECs) to other automakers. Take away these RECs and Tesla&#39;s profits aren&#39;t even remotely as impressive.</p><p>Valued at nearly 130 times Wall Street&#39;s forward-year earnings in an industry where single-digit earnings multiples are commonplace, I&#39;d have to think Tesla&#39;s stock is due for a major reversion.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks I'd Sell Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks I'd Sell Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-29 20:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/29/5-stocks-id-sell-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For many investors, the New Year is a time of reflection. They're thinking about what trends they want to buy into for the upcoming year and what stocks might help make them rich.However, reflection ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/29/5-stocks-id-sell-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4108":"电影和娱乐","SAVA":"Cassava Sciences Inc","GME":"游戏驿站","AMC":"AMC院线","BK4527":"明星科技股","BK4547":"WSB热门概念","BK4534":"瑞士信贷持仓","TSLA":"特斯拉","MSTR":"MicroStrategy","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4555":"新能源车","BK4023":"应用软件","BK4007":"制药","BK4099":"汽车制造商","BK4076":"电脑与电子产品零售","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/29/5-stocks-id-sell-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195545489","content_text":"For many investors, the New Year is a time of reflection. They're thinking about what trends they want to buy into for the upcoming year and what stocks might help make them rich.However, reflection is a two-way street. Just as there are great companies that can make investors wealthy, there are stocks that could cost investors a lot of money and should be avoided at all costs. Below are five stocks investors should consider selling right now.Image source: Getty Images.AMC EntertainmentIt's no secret that I believe movie theater chain AMC Entertainment (NYSE:AMC) is the most overvalued stock on Wall Street.For those of you who may not have followed the AMC \"made for TV drama\" that's occurred this year, the company's shares are up more than 1,200% following an epic short squeeze earlier this year. Short-sellers (investors betting on a security's price to decline) were caught off-guard when AMC was able to save itself from imminent bankruptcy by selling 164 million shares of stock and issuing high-interest debt. But with this short squeeze now in the rearview mirror, AMC's abysmal operating performance, bloated balance sheet, and declining bargaining power with movie studios are in plain view.For example, before the pandemic took effect, AMC was regularly securing theatrical exclusivity deals of 75 to 90 days. Nowadays, AMC is lucky to secure 45-day theatrical exclusivity. Even taking into account that most revenue is picked up in the first couple of weeks, this 30- to 45-day reduction in exclusivity is going to pinch AMC. It's also bad news considering that inflation-adjusted domestic box office sales have been in decline since 2002.The bigger issue, as I've stated over and over, is AMC can't make good on its liabilities. It has $5.45 billion in outstanding debt at roughly an 8% average interest rate. Keep that rate in mind, because lending rates are pretty much at historic lows. It also has over $1 billion in aggregate debt due in late 2026 and mid-2027 that's valued at more than 30% below face value. With the company hemorrhaging cash and not able to sell any additional stock thanks to its impassioned but misguided retail investors, it looks to be making a slow walk toward a chapter 11 bankruptcy reorganization.Suffice it to say, AMC Entertainment is a stock investors can confidently sell right now.Image source: Getty Images.MicroStrategyA second stock investors should strongly consider selling right now is \"enterprise analytics software company\" MicroStrategy (NASDAQ:MSTR). I have \"enterprise analytics software company\" in quotations because CEO Michael Saylor has effectively ignored this stagnant part of the company's operations and turned MicroStrategy into a leveraged gamble on Bitcoin (CRYPTO:BTC).According to the company's investor presentation earlier this month, it's holding 122,478 Bitcoin at an average price of $29,861.  The issue with this strategy is threefold, in my view.First, I'm not convinced Bitcoin is a sound investment. I recently outlined my views on Bitcoin, which centers on its false scarcity and it's less-than-stellar network performance. Bitcoin is constantly being out-innovated when it comes to payments and nonfinancial blockchain applications.Second, MicroStrategy destroyed a reasonably safe balance sheet by piling on more than $2 billion in debt and issuing $900 million in stock, all of which was used to buy Bitcoin. Saylor has leveraged a public company's future on an asset that produces nothing.And third, I believe Saylor is a poor leader. Earlier this year, Saylor told the world in an interview to \"go mortgage your house and buy Bitcoin with it.\" This is incredibly bad advice, and all the more reason to avoid MicroStrategy.Image source: Getty Images.Cassava SciencesAnother stock investors can sell right now is clinical-stage biotech stock Cassava Sciences (NASDAQ:SAVA).Cassava made waves in the first quarter when it announced positive interim analysis data from its open-label study of simufilam for patients with Alzheimer's disease. The data showed both cognition and behavior score improvements at the six-month mark. Since Alzheimer's has no cure, any positive clinical data tends to be well-received.But there are two glaring issues that should send folks scurrying to the sidelines. First of all, the track record of success for clinical-stage therapeutics targeting Alzheimer's disease is incredibly low. While we've witnessed plenty of early stage success, virtually all late-stage Alzheimer's trials end in failure. This isn't a knock against the research, so much as recognizing that tackling the blood-brain barrier is tricky.The second concern is that Cassava Sciences is facing allegations of manipulating its trial data. The company also announced in November that federal agencies are investigating its practices, without specifically naming the federal agencies in question. Keeping in mind that some of the allegations have come from firms shorting the stock, this is a headache you're better off letting someone else deal with.Image source: Getty Images.GameStopInvestors should also considering selling the original meme stock, GameStop (NYSE:GME).A few weeks before AMC ascended to the heavens on its short squeeze, GameStop's high short interest attracted retail investors. In fact, GameStop's short interest was higher than any publicly traded company, as of mid-January, making it the perfect candidate for an epic squeeze. However, with this short-term event now over, investors are forced to grapple with GameStop's poor operating performance.On the positive side, GameStop was able to raise sufficient capital from selling its stock to rid its balance sheet of debt. This net-cash position, coupled with the long-term growth potential of digital gaming, means there are no bankruptcy concerns, unlike with AMC.But GameStop was notably late in shifting its strategy to include digital gaming. Nowadays, the company is busy shuttering stores in an effort to lower its expenses and back its way into the profit column. The company's large brick-and-mortar presence is expected to work against it for the foreseeable future, and could keep it from profitability for a few years.Further, Wall Street has been unimpressed with management's lack of concrete steps that'll be taken to turn the business around. Even with a hefty cash balance, GameStop is grossly overvalued.A Tesla Model S charging. Image source: Tesla Motors.Tesla MotorsLast, but certainly not least, investors should consider giving electric vehicle (EV) manufacturer Tesla Motors (NASDAQ:TSLA) the boot.Tesla has managed to do a lot of great things with its first-mover advantage. The company is on pace to deliver more than 800,000 EVs in 2021, and CEO Elon Musk has watched his company deliver its two largest operating profits since inception this year. The range, capacity, and power associated with Tesla's batteries has been superior as well.Yet, these competitive advantages are unlikely to last given that all of the world's largest auto companies are throwing billions of dollars at EV research. For instance, General Motors and Ford Motor Company are respectively investing $35 billion and $30 billion in next-generation automobiles, with both companies bringing 30 new EVs to market by 2025. Tesla's first-mover advantage will fade sooner than later.What's more, Tesla's income statement has been aided by selling Bitcoin at a profit earlier this year, as well as selling renewable energy credits (RECs) to other automakers. Take away these RECs and Tesla's profits aren't even remotely as impressive.Valued at nearly 130 times Wall Street's forward-year earnings in an industry where single-digit earnings multiples are commonplace, I'd have to think Tesla's stock is due for a major reversion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":684,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607825628,"gmtCreate":1639526931755,"gmtModify":1639533389982,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"AiYO, why tiger articles are getting more toxicnowadays like seeking alpha and motley fools.Flip prata from so many news channels.","listText":"AiYO, why tiger articles are getting more toxicnowadays like seeking alpha and motley fools.Flip prata from so many news channels.","text":"AiYO, why tiger articles are getting more toxicnowadays like seeking alpha and motley fools.Flip prata from so many news channels.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607825628","repostId":"1197497046","repostType":4,"repost":{"id":"1197497046","kind":"news","pubTimestamp":1639526704,"share":"https://www.laohu8.com/m/news/1197497046?lang=&edition=full","pubTime":"2021-12-15 08:05","market":"sg","language":"en","title":"Renewed Selling Pressure Likely For Singapore Stock Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1197497046","media":"RTTNews","summary":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen mor","content":"<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.</p>\n<p>The global forecast for the Asian&nbsp;markets&nbsp;is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.</p>\n<p>The STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.</p>\n<p>For the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.</p>\n<p>Among the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.</p>\n<p>The lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.</p>\n<p>The Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&amp;P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.</p>\n<p>Concerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.</p>\n<p>Potentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.</p>\n<p>Lingering worries about the new Omicron variant of the&nbsp;coronavirus&nbsp;may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.</p>\n<p>Crude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.</p>\n<p>Closer to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Renewed Selling Pressure Likely For Singapore Stock Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRenewed Selling Pressure Likely For Singapore Stock Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 08:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau...</p>\n\n<a href=\"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197497046","content_text":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.\nThe global forecast for the Asian markets is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.\nThe STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.\nFor the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.\nThe lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.\nThe Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.\nConcerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.\nPotentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.\nLingering worries about the new Omicron variant of the coronavirus may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.\nCrude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.\nCloser to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.","news_type":1},"isVote":1,"tweetType":1,"viewCount":997,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604648763,"gmtCreate":1639393420656,"gmtModify":1639394148590,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"must come down first then can hoot.&nbsp;","listText":"must come down first then can hoot.&nbsp;","text":"must come down first then can hoot.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604648763","repostId":"2190677202","repostType":4,"repost":{"id":"2190677202","kind":"highlight","pubTimestamp":1639353437,"share":"https://www.laohu8.com/m/news/2190677202?lang=&edition=full","pubTime":"2021-12-13 07:57","market":"us","language":"en","title":"Tesla Stock: Headed to $1,580?","url":"https://stock-news.laohu8.com/highlight/detail?id=2190677202","media":"Motley Fool","summary":"One analyst thinks the electric-car maker's shares could rise 55% over the next 12 months.","content":"<p><b>Tesla</b> (NASDAQ:TSLA) has taken a hit recently. The stock has slid 16% since the beginning of November, even as the <b>S&amp;P 500</b> rose more than 2% over that same timeframe.</p>\n<p>But despite the stock's bearish trend recently, one analyst thinks the electric-car maker's shares will soar over the next 12 months. The analyst's updated price target for the stock calls for an impressive 55% upside from where shares closed on Friday. Based on Tesla's share count today, this implies a $1.6 trillion market capitalization.</p>\n<p>Here's why this analyst is so bullish.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/08e769c2d92397bfa34e2a502c09a26b\" tg-width=\"700\" tg-height=\"525\" referrerpolicy=\"no-referrer\"><span>Tesla factory. Image source: The Motley Fool.</span></p>\n<h2>55% upside?</h2>\n<p>Last Wednesday, New Street analyst and longtime Tesla bull Pierre Ferragu boosted his 12-month price target on Tesla stock from $1,290 to $1,580.</p>\n<p>Ferragu justifies his price target with a view for record fourth-quarter deliveries, impressive production rates at the company's factory in Shanghai, huge revenue growth next year, and more.</p>\n<p>Starting with Ferragu's estimates for Tesla's fourth-quarter deliveries, he says that the electric-car company's deliveries could come in as high as 280,000 to 285,000 in Q4. The midpoint of this range would imply 56% year-over-year growth and 17% sequential growth -- an impressive feat in a supply constrained environment. This would put total deliveries for the year at 910,000, or about 87% higher than last year.</p>\n<p>The analyst also thinks that Tesla's total revenue next year can approach $80 billion. This is about $9 billion higher than the current consensus analyst estimate calls for. Notably, Ferragu believes that Tesla is now producing electric vehicles at its factory in China at an annualized rate of more than 700,000 -- well above what Tesla initially said the factory would do. Adding this production to Tesla's factory in Fremont and the company's new factories in Texas and Germany will help sales soar next year, the analyst believes.</p>\n<h2>Valuation may be the biggest risk facing Tesla investors</h2>\n<p>But the riskiest part of this thesis may be Ferragu's view on the high valuation he believes Tesla stock will command. Ferragu thinks Tesla can trade at 50 to 100 times earnings for the foreseeable future. While the electric-car maker definitely deserves to trade at a multiple like this today, based on the company's strong growth prospects, there's always a chance that growth slows materially in the future. If growth does slow materially over the next five years, Tesla's price-to-earnings ratio could fall below Ferragu's target range.</p>\n<p>Further, investors should note that Tesla has a price-to-earnings ratio of over 300 today. So there's already huge growth priced in from the electric-car maker. Of course, analysts agree that earnings are about to soar. On average, analysts believe that Tesla's earnings per share will increase at an average annualized rate of 73% over the next five years.</p>\n<p>So while Tesla stock is looking more attractive after its recent sell-off, there are still risks to owning shares -- particularly when it comes to the stock's sky-high valuation. Tesla will need to keep executing extremely well over the long haul in order for its stock to be an outperformer from this level.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock: Headed to $1,580?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock: Headed to $1,580?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 07:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/12/tesla-stock-headed-to-1580/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla (NASDAQ:TSLA) has taken a hit recently. The stock has slid 16% since the beginning of November, even as the S&P 500 rose more than 2% over that same timeframe.\nBut despite the stock's bearish ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/12/tesla-stock-headed-to-1580/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4555":"新能源车","BK4099":"汽车制造商","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4534":"瑞士信贷持仓","TSLA":"特斯拉","BK4527":"明星科技股"},"source_url":"https://www.fool.com/investing/2021/12/12/tesla-stock-headed-to-1580/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190677202","content_text":"Tesla (NASDAQ:TSLA) has taken a hit recently. The stock has slid 16% since the beginning of November, even as the S&P 500 rose more than 2% over that same timeframe.\nBut despite the stock's bearish trend recently, one analyst thinks the electric-car maker's shares will soar over the next 12 months. The analyst's updated price target for the stock calls for an impressive 55% upside from where shares closed on Friday. Based on Tesla's share count today, this implies a $1.6 trillion market capitalization.\nHere's why this analyst is so bullish.\nTesla factory. Image source: The Motley Fool.\n55% upside?\nLast Wednesday, New Street analyst and longtime Tesla bull Pierre Ferragu boosted his 12-month price target on Tesla stock from $1,290 to $1,580.\nFerragu justifies his price target with a view for record fourth-quarter deliveries, impressive production rates at the company's factory in Shanghai, huge revenue growth next year, and more.\nStarting with Ferragu's estimates for Tesla's fourth-quarter deliveries, he says that the electric-car company's deliveries could come in as high as 280,000 to 285,000 in Q4. The midpoint of this range would imply 56% year-over-year growth and 17% sequential growth -- an impressive feat in a supply constrained environment. This would put total deliveries for the year at 910,000, or about 87% higher than last year.\nThe analyst also thinks that Tesla's total revenue next year can approach $80 billion. This is about $9 billion higher than the current consensus analyst estimate calls for. Notably, Ferragu believes that Tesla is now producing electric vehicles at its factory in China at an annualized rate of more than 700,000 -- well above what Tesla initially said the factory would do. Adding this production to Tesla's factory in Fremont and the company's new factories in Texas and Germany will help sales soar next year, the analyst believes.\nValuation may be the biggest risk facing Tesla investors\nBut the riskiest part of this thesis may be Ferragu's view on the high valuation he believes Tesla stock will command. Ferragu thinks Tesla can trade at 50 to 100 times earnings for the foreseeable future. While the electric-car maker definitely deserves to trade at a multiple like this today, based on the company's strong growth prospects, there's always a chance that growth slows materially in the future. If growth does slow materially over the next five years, Tesla's price-to-earnings ratio could fall below Ferragu's target range.\nFurther, investors should note that Tesla has a price-to-earnings ratio of over 300 today. So there's already huge growth priced in from the electric-car maker. Of course, analysts agree that earnings are about to soar. On average, analysts believe that Tesla's earnings per share will increase at an average annualized rate of 73% over the next five years.\nSo while Tesla stock is looking more attractive after its recent sell-off, there are still risks to owning shares -- particularly when it comes to the stock's sky-high valuation. Tesla will need to keep executing extremely well over the long haul in order for its stock to be an outperformer from this level.","news_type":1},"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604648628,"gmtCreate":1639393360602,"gmtModify":1639395145155,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"finally its standing up shining like a star.","listText":"finally its standing up shining like a star.","text":"finally its standing up shining like a star.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604648628","repostId":"1199964643","repostType":4,"isVote":1,"tweetType":1,"viewCount":1002,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":819524151,"gmtCreate":1630079037573,"gmtModify":1704955718546,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","text":"$Cassava Sciences Inc(SAVA)$ Cassava Sciences Releases Statement Regarding Plasma p-tau (globenewswire.com)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819524151","isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":696663312,"gmtCreate":1640683833505,"gmtModify":1640685636531,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"‌<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>‌True Science will kill the Shorts.","listText":"‌<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>‌True Science will kill the Shorts.","text":"‌$Cassava Sciences Inc(SAVA)$‌True Science will kill the Shorts.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696663312","isVote":1,"tweetType":1,"viewCount":662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":815834802,"gmtCreate":1630664153206,"gmtModify":1631887192604,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>It's almost time to average in at current price levels. &nbsp;Baby steps at a time, go easy. &nbsp;[YoYo]&nbsp;[Call]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>It's almost time to average in at current price levels. &nbsp;Baby steps at a time, go easy. &nbsp;[YoYo]&nbsp;[Call]&nbsp;","text":"$Cassava Sciences Inc(SAVA)$It's almost time to average in at current price levels. Baby steps at a time, go easy. [YoYo] [Call]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/815834802","isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819437902,"gmtCreate":1630085057706,"gmtModify":1704955808226,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>Lunch break isover, time to go GREEN![Smart]&nbsp;","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>Lunch break isover, time to go GREEN![Smart]&nbsp;","text":"$Cassava Sciences Inc(SAVA)$Lunch break isover, time to go GREEN![Smart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819437902","isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":604648551,"gmtCreate":1639393393793,"gmtModify":1639394148249,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"rollercoaster piece; sitting on bench","listText":"rollercoaster piece; sitting on bench","text":"rollercoaster piece; sitting on bench","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604648551","repostId":"1180589333","repostType":4,"isVote":1,"tweetType":1,"viewCount":1197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604648141,"gmtCreate":1639393336330,"gmtModify":1639394147844,"author":{"id":"3575010783330312","authorId":"3575010783330312","name":"咸蛋超人POT","avatar":"https://static.tigerbbs.com/ffe12d12ec49236cc05d807be8348dc0","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575010783330312","authorIdStr":"3575010783330312"},"themes":[],"htmlText":"CHPT a contrary sentiment; pull and push effect due to their quality.&nbsp; AMRS go go go!","listText":"CHPT a contrary sentiment; pull and push effect due to their quality.&nbsp; AMRS go go go!","text":"CHPT a contrary sentiment; pull and push effect due to their quality. AMRS go go go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604648141","repostId":"2190467769","repostType":4,"repost":{"id":"2190467769","kind":"highlight","pubTimestamp":1639367630,"share":"https://www.laohu8.com/m/news/2190467769?lang=&edition=full","pubTime":"2021-12-13 11:53","market":"us","language":"en","title":"3 Growth Stocks to Fuel Your 2022 Financial Freedom","url":"https://stock-news.laohu8.com/highlight/detail?id=2190467769","media":"Motley Fool","summary":"This basket of industrial and electric vehicle stocks is primed to pole vault your portfolio.","content":"<p>2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful for this year. However, those gains have come and gone. The challenge now is finding the best places to invest for 2022 and beyond.</p>\n<p><b>Corteva</b> (NYSE:CTVA), <b>Amyris</b> (NASDAQ:AMRS), and <b>ChargePoint Holdings</b> (NYSE:CHPT) are three growth stocks that could bring you closer to securing financial freedom. Here's what makes each a great buy now.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F656760%2Fgettyimages-1304258192.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Investor confidence is growing in the agriscience company</h2>\n<p><b>Lee Samaha (Corteva):</b> After a few years of questionable performance, it looks like Corteva is starting to realize the potential in its business. The company was created out of the DowDuPont merger and subsequent breakup. As such, it's the leading U.S. player in seed and crop protection, competing with international companies such as Monsanto owner <b>Bayer</b>, <b>BASF</b>, and <b>Syngenta</b>.</p>\n<p>The potential in the business lies in the expectation that Corteva can improve productivity and catch up to the kind of margins enjoyed by its peers. Among the ways it can enhance margin is by selling more of its products under its patents. This means Corteva will lower the share of revenue it pays in royalty costs to other companies, and Corteva's profit margin will go up.</p>\n<p>The good news is the company is making progress on all fronts. For example, management recently reaffirmed its target of $2.8 billion to $3.1 billion in adjusted earnings before interest, taxation, depreciation, and amortization (EBITDA) in 2022, rising from $2.5 billion to $2.6 billion in 2021. Moreover, management noted that the adoption rate of its Enlist (seed and crop protection) system was better than it had expected in 2021. In addition, there's a strong pipeline of other products under Corteva's patents coming through in the next few years.</p>\n<p>As such, a combination of mid-single-digit revenue growth and margin expansion promises to deliver double-digit earnings growth over the medium term for Corteva.</p>\n<h2>Supply chain woes knocked this stock down, but it's poised to get back up again</h2>\n<p><b>Scott Levine (Amyris): </b>Shares of synthetic biology specialist Amyris have both thrilled and devastated investors in 2021. While the stock skyrocketed more than 209% through the first three months of the year, it came back to earth in the second half -- particularly last month, when it fell 54%. Although it's the bears who are most interested in the stock at the moment, the company has several catalysts on the horizon in 2022 that could propel it considerably higher.</p>\n<p>One of the primary reasons for the stock's sell-off last month was concern related to supply chain headwinds facing Amyris and fear that they'd continue to plague the company in the coming months. But Amyris is working to shore up its supply chain, developing two facilities in Brazil and Nevada, both of which are expected to commence operations in the first half of 2022. According to John Melo, the company's CEO, the importance of the two facilities will have a material impact on its finances. On the company's third-quarter conference call, Melo said, \"These facilities will not only provide us much more resilience on the supply chain, they will also reduce our operating costs significantly and improve our gross margin by about 1,000 basis points.\"</p>\n<p>The company's growth, however, transcends an improvement in its gross margin as management forecasts revenue will rise to over $500 million in 2022 and $1 billion in 2023. For some perspective, Amyris reported $173 million on the top line in 2020, and it has booked sales of $357 million over the past 12 months. Looking toward the bottom of the income statement, investors can expect the company to report positive earnings before interest, taxes, depreciation, and amortization (EBITDA) -- a feat it last achieved in 2014.</p>\n<p>As companies look to source their products with sustainable ingredients, Amyris and its line of synbio-based products will likely become increasingly appealing. For forward-looking investors who have the patience to let this growth story play out, the stock's recent sell-off offers a great opportunity to pick up shares on the cheap, leaving more money available to splurge on presents for friends and loved ones.</p>\n<h2>This EV charging stock is off to the races</h2>\n<p><b>Daniel Foelber (ChargePoint Holdings): </b>America's largest electric vehicle (EV) charging infrastructure company, ChargePoint, reported third-quarter fiscal year 2022 earnings on Tuesday that exceeded expectations. After generating $65 million in revenue, ChargePoint now expects to earn between $73 million and $78 million in fourth-quarter revenue, bringing its full-year sales to between $235 million and $240 million. If it hits its target, ChargePoint would have grown its top line by 63% compared to last year. For context, consider that ChargePoint earned $146 million in revenue in fiscal year 2021 and $144.5 million in fiscal year 2020 revenue.</p>\n<p>The growth rate is impressive, but even if ChargePoint hits its revenue target it would still have a price-to-sales ratio of 28.7, which is more expensive than some of the market's hottest growth stocks. However, COVID-19 stunted its fiscal year 2021 growth and the company could now be off to the races now that EV investment is increasing. ChargePoint expects its rise to be directly proportional to the growth rate of U.S. passenger EV sales. Between 2020 to 2026, ChargePoint expects U.S. passenger EV sales to rise at a compound annual growth rate (CAGR) of 41% as more affordable EVs come on stream and consumer demand for EVs increases.</p>\n<p>Although still a long way from profitability, ChargePoint is an excellent catch-all way to expose your portfolio to the growth of EVs without having to risk picking a particular automaker to win out.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Growth Stocks to Fuel Your 2022 Financial Freedom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Growth Stocks to Fuel Your 2022 Financial Freedom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 11:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHPT":"ChargePoint Holdings Inc.","AMRS":"阿米瑞斯","BK4109":"特种化学制品","CAGR":"California Grapes International, Inc.","BK4542":"充电桩","BK4096":"电气部件与设备","CTVA":"Corteva, Inc.","BK4093":"化肥与农用药剂","BK4535":"淡马锡持仓","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190467769","content_text":"2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful for this year. However, those gains have come and gone. The challenge now is finding the best places to invest for 2022 and beyond.\nCorteva (NYSE:CTVA), Amyris (NASDAQ:AMRS), and ChargePoint Holdings (NYSE:CHPT) are three growth stocks that could bring you closer to securing financial freedom. Here's what makes each a great buy now.\nImage source: Getty Images.\nInvestor confidence is growing in the agriscience company\nLee Samaha (Corteva): After a few years of questionable performance, it looks like Corteva is starting to realize the potential in its business. The company was created out of the DowDuPont merger and subsequent breakup. As such, it's the leading U.S. player in seed and crop protection, competing with international companies such as Monsanto owner Bayer, BASF, and Syngenta.\nThe potential in the business lies in the expectation that Corteva can improve productivity and catch up to the kind of margins enjoyed by its peers. Among the ways it can enhance margin is by selling more of its products under its patents. This means Corteva will lower the share of revenue it pays in royalty costs to other companies, and Corteva's profit margin will go up.\nThe good news is the company is making progress on all fronts. For example, management recently reaffirmed its target of $2.8 billion to $3.1 billion in adjusted earnings before interest, taxation, depreciation, and amortization (EBITDA) in 2022, rising from $2.5 billion to $2.6 billion in 2021. Moreover, management noted that the adoption rate of its Enlist (seed and crop protection) system was better than it had expected in 2021. In addition, there's a strong pipeline of other products under Corteva's patents coming through in the next few years.\nAs such, a combination of mid-single-digit revenue growth and margin expansion promises to deliver double-digit earnings growth over the medium term for Corteva.\nSupply chain woes knocked this stock down, but it's poised to get back up again\nScott Levine (Amyris): Shares of synthetic biology specialist Amyris have both thrilled and devastated investors in 2021. While the stock skyrocketed more than 209% through the first three months of the year, it came back to earth in the second half -- particularly last month, when it fell 54%. Although it's the bears who are most interested in the stock at the moment, the company has several catalysts on the horizon in 2022 that could propel it considerably higher.\nOne of the primary reasons for the stock's sell-off last month was concern related to supply chain headwinds facing Amyris and fear that they'd continue to plague the company in the coming months. But Amyris is working to shore up its supply chain, developing two facilities in Brazil and Nevada, both of which are expected to commence operations in the first half of 2022. According to John Melo, the company's CEO, the importance of the two facilities will have a material impact on its finances. On the company's third-quarter conference call, Melo said, \"These facilities will not only provide us much more resilience on the supply chain, they will also reduce our operating costs significantly and improve our gross margin by about 1,000 basis points.\"\nThe company's growth, however, transcends an improvement in its gross margin as management forecasts revenue will rise to over $500 million in 2022 and $1 billion in 2023. For some perspective, Amyris reported $173 million on the top line in 2020, and it has booked sales of $357 million over the past 12 months. Looking toward the bottom of the income statement, investors can expect the company to report positive earnings before interest, taxes, depreciation, and amortization (EBITDA) -- a feat it last achieved in 2014.\nAs companies look to source their products with sustainable ingredients, Amyris and its line of synbio-based products will likely become increasingly appealing. For forward-looking investors who have the patience to let this growth story play out, the stock's recent sell-off offers a great opportunity to pick up shares on the cheap, leaving more money available to splurge on presents for friends and loved ones.\nThis EV charging stock is off to the races\nDaniel Foelber (ChargePoint Holdings): America's largest electric vehicle (EV) charging infrastructure company, ChargePoint, reported third-quarter fiscal year 2022 earnings on Tuesday that exceeded expectations. After generating $65 million in revenue, ChargePoint now expects to earn between $73 million and $78 million in fourth-quarter revenue, bringing its full-year sales to between $235 million and $240 million. If it hits its target, ChargePoint would have grown its top line by 63% compared to last year. For context, consider that ChargePoint earned $146 million in revenue in fiscal year 2021 and $144.5 million in fiscal year 2020 revenue.\nThe growth rate is impressive, but even if ChargePoint hits its revenue target it would still have a price-to-sales ratio of 28.7, which is more expensive than some of the market's hottest growth stocks. However, COVID-19 stunted its fiscal year 2021 growth and the company could now be off to the races now that EV investment is increasing. ChargePoint expects its rise to be directly proportional to the growth rate of U.S. passenger EV sales. Between 2020 to 2026, ChargePoint expects U.S. passenger EV sales to rise at a compound annual growth rate (CAGR) of 41% as more affordable EVs come on stream and consumer demand for EVs increases.\nAlthough still a long way from profitability, ChargePoint is an excellent catch-all way to expose your portfolio to the growth of EVs without having to risk picking a particular automaker to win out.","news_type":1},"isVote":1,"tweetType":1,"viewCount":789,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}